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AACATTTACATACAGCCAGTGTAGATGACACATTGATTTAAAAAAAATAGTGCGAGTGCTTTGA
ATCTGTGATTTCAAATATCGAATCAAAAGGACTGCATTAGTGTTGTGGGAGTTAAAGTGTTTGT
GAGAATAGACCAACGACCATGCAAGATGGCGGGTGACGCCTGCATACTGGTGACGGTGCTTCTC
ACCTTCGCAACATCAGTTTTCGGGCAAGAAACAACATCGTCGAGATGTTACTACATGACTGACG
CTATTCCGAGGGAACCGAAACCGGATGATTTGCCTGACTTAGAATGGACTGGTGGATGGACCGA
CTGGCCTTTGATCCCGGCTGAGCCAAGAGACGACGTGTGCATAAACGGCTGGTACCCACAACTC
ACCAGCACTTCTCTCGGCACCATCATCATCCACATGGAAGAGGAGATCGAGGGAGATGTTGCTA
TCGCTAAACTTAACTATGATGGTTCTGGAACCCCAGAAATTGTCCAGCCGATGGTTATAGGATC
TTCTAACCTGCTAAGTCCAGAGATCCGGAATGAAAACGGGGCGTGGTACCTTTATATAACCAAT
AGGCAAGATTATGAAACACCAACAATGCGTCGGTATACATTCGACGTCCGAGTGCCAGACGAGA
CTCGTGCGGCACGAGTGAGTCTGTCCATCGAAAACATTGACGATAACGACCCTATCGTCAGGGT
GCTAGACGCTTGCCAAGTGCCGGAATTGGGGGAGCCTCGACTAACAGACTGCGTTTACCAAGTG
TCAGACGAAGATGGGAGGCTTAGTATCGAGCCCATGACATTCCGCCTCACATCAGACCGTGAAG
ACGTACAGATATTCTATGTGGAGCCAGCTCACATTACTGGTGATTGGTTCAACATGCAAATTAC
TATCGGTATCCTATCAGCGCTTAACTTCGAAAGCAACCCGCTGCACATCTTTCAAATCACTGCT
TTGGACTCCTGGCCCAACAACCATACGGTGACGGTGATGGTGCAAGTCCAGAATGTGGAACACC
GACCGCCGCGATGGATGGAAATCTTCGCAGTCCAGCAGTTTGACGAGATGACGGAGCAGCAATT
CCAGGTGCGCGCCATCGACGGAGACACTGGCATCGGGAAAGCTATACACTATACCCTCGAGACA
GATGAGGAAGAAGATTTGTTCTTCATCGAAACACTTCCGGGCGGCCATGACGGAGCCATCTTCA
GCACTGCCATGATTGATGTGGATAGGCTCCGGCGAGATGTCTTCAGACTGTCCCTGGTGGCATA
CAAGTACGACAATGTGTCCTTCGCCACCCCGACACCCGTCGTGATCATAGTCAATGACATCAAC
AACAAGAAACCCCAACCGCTGCAAGATGAGTACACAATCTCCATAATGGAAGAAACTCCACTGT
CGCTGAATTTTGCTGAACTTTTTGGTTTCTATGATGAAGATTTGATCTACGCACAATCCTTGGT
GGAAATACAAGGCGAGAACCCTCCAGGCGTAGAGCAAGCGTTTTATATTGCGCCCACCGCAGGC
TTCCAGAACCAGACATTCGCCATAGGGACTCAAGATCACCGAATGCTGGATTATGAGGATGTTC
CTTTCCAAAACATCAAGCTCAAGGTAATAGCAACGGACCGTGACAATACCAATTTTACTGGAGT
CGCGGAAGTCAACGTGAACCTGATTAATTGGAACGACGAGGAGCCGATCTTTGAGGAAGACCAG
CTCGTTGTCAAGTTCAAGGAGACTGTACCCAAGGACTATCACGTCGGCAGACTGAGGGCTCACG
ACCGGGACATAGGAGACAGCGTTGTGCATTCCATCTTGGGAAATGCGAATACATTTTTGAGAAT
CGACGAAGAAACTGGCGACATATACGTAGCTATTGATGACGCGTTCGATTATCACAGACAGAAT
GAATTTAACATACAAGTTCGCGCTCAGGACACCATGTCGGAGCCAGAGTCCAGGCATACAGCGG
CTGCTCAGCTGGTCATAGAACTCGAGGACGTCAACAACACACCTCCTACTCTGAGGCTGCCTCG
CGTAAGTCCGTCTGTAGAAGAGAATGTGCCAGAGGGCTTTGAAATCAACCGGGAGATAACCGCC
ACGGACCCTGACACCACAGCATACCTGCAGTTTGAAATAGATTGGGACACATCCTTTGCCACTA
AACAGGGGCGTGATACCAATCCAATAGAGTTCCACGGATGCGTGGATATAGAAACCATCTTCCC
AAACCCAGCCGACACCAGAGAGGCTGTGGGGCGAGTGGTAGCGAAGGGGATCCGCCATAACGTG
ACCATCCATTTTGAAGAGTTTGAATTTCTCTACCTCACAGTGAGAGTTCGGGACTTGCACACAG
ATGACGGACGAGATTATGATGAATCTACCTTCACGGTAATAATAATAGATATGAACGACAACTG
GCCTATCTGGGCGTCTGGTTTCCTGAACCAGACCTTCAGTATTCGGGAGCGATCATCTACCGGC
GTCGTCATCGGGTCCGTACTCGCTACAGACATTGATGGCCCACTTTACAACCAAGTCCGGTACA
CCATTATCCCCCAGGAAGATACTCCTGAAGGTCTAGTCCAGATACATTTCGTTACGGGTCAAAT
TACAGTTGATGAGAATGGTGCAATCGACGCTGATATTCCACCTCGTTGGCACCTCAACTACACG
GTTATAGCCAGCGACAAATGTTCTGAAGAAAATGAAGAGAACTGTCCCCCGGATCCAGTGTTCT
GGGATACTCTGCGCGACAATGTAATTAACATCGTGGACATAAACAACAAGGTCCCGGCAGCAGA
CCTCAGTCGATTCAACGAAACGGTGTACATTTATGAAAATGCACCCGATTTCACGAACGTGGTC
Figure 1A
U.S. Patent Aug. 22, 2006 Sheet 2 of 9 US 7,094,554 B2
AAGATATACTCCATCGACGAAGACAGAGACGAAATATATCACACGGTGCGGTACCAGATCAATT
ATGCTGTGAACCAACGGCTGCGAGACTTCTTCGCCATAGACCTGGATTCAGGCCAGGTGTACGT
GGAGAACACCAACAATGAGCTCCTGGATCGGGACAGAGGCGAAGACCAACACAGGATATTCATT
AACCTCATTGACAACTTTTATAGCGAAGGAGATGGAAATAGAAATGTAAACACTACAGAGGTGC
TGGTGATACTATTAGATGAGAATGACAACGCTCCTGAATTGCCGACTCCAGAAGAGCTGAGTTG
GAGCATTTCCGAGGATTTACAAGAGGGTATAACACTCGATGGCGAAAGCGATGTGATATACGCA
CCGGATATAGACAAAGAGGACACGCCAAACTCTCACGTTGGCTACGCAATCCTGGCCATGACAG
TCACCAATAGAGACCTGGACACTGTTCCGAGACTTCTCAACATGCTGTCGCCTAACAACGTAAC
CGGATTCCTCCAGACAGCAATGCCTTTGAGAGGATATTGGGGGACTTACGATATAAGTGTACTG
GCGTTCGACCACGGTATTCCTCAGCAGATATCTCATGAGGTGTATGAATTGGAAATTCGACCTT
ACAATTACAATCCTCCTCAGTTCGTTTTTCCTGAATCCGGGACGATTCTACGACTGGCTTTGGA
ACGCGCAGTGGTAAATAATGTTTTGTCACTTGTAAACGGTGACCCGTTAGACAGGATACAAGCA
ATTGACGACGATGGTCTTGATGCTGGCGTGGTGACTTTCGATATTGTTGGAGATGCTGATGCGT
CAAACTACTTCAGAGTAAATAATGATGGCGACAGCTTTGGAACCTTGTTGCTGACACAGGCGCT
TCCTGAGGAAGGCAAGGAATTTGAGGTTACCATCCGGGCTACAGACGGCGGAACAGAACCTCGA
TCATATTCAACAGACTCCACTATAACAGTCCTCTTCGTTCCGACTTTGGGTGATCCGATCTTTC
AAGATAACACTTACTCAGTAGCATTCTTTGAAAAAGAGGTTGGCTTGACTGAGAGGTTCTCGCT
CCCACATGCAGAGGACCCTAAGAACAAACTCTGCACTGACGACTGTCACGATATTTACTACAGG
ATCTTTGGTGGTGTGGATTACGAGCCATTTGACCTGGACCCGGTGACGAACGTGATCTICCTGA
AATCAGAACTAGACCGGGAGACCACTGCTACGCATGTGGTGCAAGTGGCAGCCAGTAATTCGCC
CACAGGAGGCGGAATACCACTCCCTGGGTCTCTTCTCACCGTCACTGTCACTGTACGAGAAGCG
GATCCACGGCCTGTGTTCGAGCAGCGTCTGTACACGGCTGGCATTTCCACTTCCGATAACATCA
ACAGGGAACTACTCACCGTTCGTGCAACTCATTCCGAAAACGCACAATTGACATATACCATCGA
AGACGGTTCTATGGCGGTGGACTCCACTCTGGAAGCCGTCAAGGACTCGGCGTTCCATCTGAAC
GCGCAGACCGGCGTCCTCATACTGAGGATACAACCTACTGCCAGCATGCAGGGCATGTTTGAGT
TCAACGTCATCGCTACTGACCCAGATGAGAAGACAGATACGGCAGAGGTGAAAGTCTACCTCAT
TTCATCCCAAAATAGGGTGTCCTTCATATTCCTGAACGATGTGGAGACGGTTGAGAGTAACAGA
GACTTTATCGCAGAAACGTTCAGCGTTGGCTTCAACATGACCTGCAATATAGATCAGGTGCTGC
CGGGCACCAACGACGCCGGGGTGATTCAGGAGGCCATGGCGGAAGTCCATGCTCACTTCATACA
GGATAACATCCCTGTGAGCGCCGACAGTATTGAAGAGCTTCGCAGTGACACTCAGCTGCTGCGC
TCCGTCCAAGGTGTGTTGAACCAACGGCTGTTGGTCCTGAACGACCTGGTGACGGGGGTCAGCC
CTGATCTCGGCACTGCCGGCGTGCAGATCACCATCTATGTGCTAGCCGGGTTGTCAGCCATCCT
TGCCTTCCTGTGCCTTATTCTGCTCATCACATTCATCGTGAGGACCCGAGCTCTGAACCGCCGT
TTGGAAGCACTGTCGATGACGAAATACGGCTCGGTGGATTCGGGGCTGAACCGAGTGGGGATAG
CGGCCCCAGGAACCAACAAACACGCCATCGAAGGCTCCAACCCCATCTGGAACGAGCAGATCAA
GGCCCCGGACTTCGATGCCATCAGTGACACATCTGACGACTCTGATCTAATCGGCATCGAGGAT
AGCCTGCAGGGAGACTTAGAAGAGAAAAGGGCAGACAAAGCAGTAGATGCCTTGGTGAAAAAGC
TGAAGAAGAACGATGGAGCCATGGGGGAATACGAATTCAAGGCCTCTCGAGCCTCTAGAACTAT
CGTGAGTCGTATTACGTATATCCAGACATGATGAGATACATTGATGAGTTTGGACAAACCGCAA
CTAGAATGCAGTGAAAAABATGCTTTATTIGTTGAAATTTGTGATGCTATTGCTTTATTIGGAA
CCATTATAAGCTGCAATAAACAAGTTAACATCATCAATTGCATTCATTTTATGTTTCAGGTTCA
GGGGGAGGTGTGGGAGGCTATCC
Figure 1B
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VLSLVNGDPL DRIQAIDDDG LDAGVVTFDI VGDADASNYF
TLLLTQALPE EGKEFEVTIR ATDGGTEPRS YSTDSTITVLCR11—? MBFQDNTYSVAFF EKEVGLTERF_SLPHAEDPKN KLCTDDCHDI
EPFDLDPVTN VIFLKSELDR ETTATHVVOV_ AASNSPTGGGCR12—TVTVREADPR PVFEORLYTA GISTSDNINR ELLTVRATHS
DGSMAVDSTL EAVKDSAFHL NAQTGVLILR IQPTASMQGM> MPDDEKTDTAEVK VYLISSQNRV SFIFLNDVET VESNRDFIAE
NIDQVLPGTN DAGVIQEAMA EVHAHFIQDN IPVSADSIEE
VOGVLNORLL VLNDLVTGVS PDLGTAGVQI TIYVLAGLSA— CYTITFIVRTRAL NRRLEALSMT KYGSVDSGLN RVGIAAPGTN
WNEQIKAPDF DAISDTSDDS DLIGIEDSLO GDLEEKRADK
KNDGAMGEYE FKASRASRTI VSRITYIOQT.
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1
PECTINOPHORA GOSSYPIELLA (PINK
BOLLWORM) BACILLUS THURINGIENSIS
TOXIN RECEPTORBT-R,
CROSS-REFERENCES TO RELATED
APPLICATIONS
This application is a divisional of U.S. Ser. No. 09/696,
115 filed 24 Oct. 2000, now U.S. Pat. No. 6,660,497, which
claims the benefit of U.S. Provisional Application No.
60/161,564, filed Oct. 26, 1999. The contents of this appli-
cation are incorporated herein by reference.
TECHNICAL FIELD OF THE INVENTION
This invention generally relates to receptors for Bacillus
thuringiensis (BT) toxin and thus to pesticides able to bind
the receptor, and to ameliorating pesticide resistance. In
particular, the invention relates to recombinant DNA and
expression systems for a novel receptor and receptor ele-
ments from Pectinophora gossypiella, the pink bollworm.
BACKGROUND OF THE INVENTION
Without limiting the scope of the invention, its back-
ground is described in connection with uses of Bacillus
thuringiensis toxins as cotton insect biocidal agents, as an
example. Cotton insect pests reduced yields by almost 10%
across the US in 1998. Insect damage reduced the overall
cotton yield by more than 1.7 million bales and produced a
financial loss of about $1.224 billion. One group in particu-
lar, the bollworm/budworm complex was the most damaging
causing a 2.7% loss. The pink bollworm, Pectinophora
gossypiella Saunders (“PBW’’), is a lepidopteran insect that
causes severe damage to cotton and is the most destructive
pest of cotton worldwide.
Bacillus thuringiensis is a gram positive, sporeforming
bacterium that forms a parasporal crystal which contains
insecticidal toxins (Bulla et al., Crit. Rev. Microbiol. (1980)
8: 147-204; Héfte and Whiteley, Microbiol. Rev. (1989) 53:
242. The effect of the toxin is mediated through binding to
specific receptors on the apical brush border of the midgut
microvillae (BBMV)of susceptible insects.
Biological control of cotton pests using B. thuringiensis
formulations and transgenic plants has been in use for a
numberofyears and is growing rapidly. Recently, transgenic
cotton plants carrying the toxin genes of BT have been
developed and sold commercially. Such transgenic plants
have a high degree of resistance to the pink bollworm
(Schnepfet al., Microbiol. Mol. Biol. Rev. (1998) 62: 775).
However, the introduction of any new insecticide into a pest
management program immediately initiates a selection pro-
cess for individuals that are resistant to the pesticide. As the
use oftransgenic crops expressing BT toxin increases, insect
resistance is expected to become more widespread.
Increased tolerance for BT toxins in several species of
insects has been reported by several investigators while
laboratory selection experiments have shownthat the use of
BT toxin formulations and transgenic plants can provoke the
developmentof resistance in the pink bollworm (Bartlett, et
al., Beltwide Cotton Conference (1995) 2: 766).
Concerns that BT toxin formulations or transgenic plants
expressing the toxin genes may evoke emergence ofeither
resistant or tolerantstrains of insects has made the search for
a better understanding of the interaction between the BT
toxin proteins and their respective insect receptors a matter
of considerable economic importance.
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In U.S. Pat. No. 5,693,491, the present inventors dis-
closed the purification and cDNA cloning of a B. thuring-
iensis toxin receptor BT-R, from larvae of the tobacco
hornworm Manduca sexta (M. Sexta). Recently, two BT
toxin receptors have been identified, purified and cloned
from the silkworm, Bombyx mori (Nagamatsuet al., Biosci.
Biotechnol. Biochem. (1998) 62: 727).
Heretofore in this field, there has been no structural
information concerning the structure and function of BT
toxin receptor of the major cotton insect pest, P. gossypiella.
Furthermore, to the inventors’ knowledge, the minimum
binding fragment encoding a consensus binding domain for
BT toxin on the BT receptor has not yet been identified.
Isolation of the minimum binding fragment could permit
cloning and structural characterization of important yet
uncharacterized BT toxin receptors from other insects of
worldwide economic importance such as P. gossypiella.
SUMMARY OF THE INVENTION
The present invention provides information and materials
for isolation and expression of novel BT crystal toxin
receptors, herein referred to as Cry toxin receptors. Gener-
ally, the invention provides structural and functional char-
acterization of a novel lepidopteran BT toxin receptor,
herein referred to as BT-R,.
AcDNAthat encodes an alternative glycoprotein receptor
from the pink bollworm that binds specifically to a B.
thuringiensis toxin has been cloned, sequenced and charac-
terized. The BT-R, cDNA permits the analysis of receptors
in pink bollworm andother insects and organismsthat affect
crop growth and development, as well as the design of
assays for the cytotoxicity and binding affinity of potential
pesticides. The clone and other methods described herein,
permit the manipulation of natural and/or introduced
homologous receptors and, thus, to specifically destroy
organisms, tissues and/or cells of the target host, including
insects resistant to toxins of B. thuringiensis.
The invention further provides purified and cloned cDNA
encoding a 200 kD receptor for the Cry1A toxinsofthe pink
bollworm, P. gossypiella. An advantage of this invention is
the identification of the minimum binding fragment encod-
ing the toxin binding domain on the BT toxin receptor.
Another advantage of this invention is the provision of
methodologies for cloning and structural characterization of
presently unknown BT receptors. Furthermore, this inven-
tion provides methods and materials for identification and
design of effective toxin binding receptors for use in com-
bating emergence of toxin resistance. Also, this invention
may be used to generate transgenic organisms expressing
toxin receptors.
BRIEF DESCRIPTION OF THE DRAWINGS
A more complete understanding of the method and appa-
ratus of the present invention may be obtained by reference
to the following Detailed Description when taken in con-
junction with the accompanying Drawings wherein:
FIGS, 1A—B show the nucleotide sequence cDNA encod-
ing the BT-R, protein from P. gossypiella (SEQ ID NO:1);
FIGS. 2A and 2B showthe aminoacid sequence of BT-R2
protein from P. gossypiella (SEQ ID NO:2). Arrowsindicate
the start site of the putative cadherin domains CR1-CR12,
SIG=signal sequence (double underline); MPD=membrane
proximal domain; CYT=cytoplasmic region. The transmem-
brane region is underlined and bold. The leucine zipper
motif LZ is underlined. N residues denote putative N-gly-
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cosylation sites. The minimum binding fragment MBF (aa
1269-1367) is also double underlined;
FIG. 3A is a graph showing the binding results of CrylA
toxins on P. gossypiella larvae brush border membrane
vesicles prepared from midgut epithelial cells;
FIG.3B is a graph showing the toxicity results of CrylA
toxins on P. gossypiella larvae and BBMV;
FIG. 4 is a map of the structure of the pink bollworm
(PBW) BT-R, cDNAs, including truncations PBW-
1210-1496, PBW-1269-1439, PBW-1367-1496, and PBW-
1269-1367 of SEQ ID NO:2 (the minimum binding frag-
ment). The binding of proteins expressed from each clone to
Cry1A toxin was identified by (+) for binding and (-) for
non-binding; and
FIGS. 5A-C illustrate an alignment of the silk worm (top
SEQ ID NO:17), the tobacco hornworm (middle SEQ ID
NO:18), and the pink bollworm (bottom SEQ ID NO:2) Cry
toxin receptors. Perfectly conserved residues are boxed.
DETAILED DESCRIPTION OF THE
PRESENTLY PREFERRED EXEMPLARY
EMBODIMENTS
The present invention will now be described more fully
hereinafter with reference to the accompanying drawings, in
which preferred embodiments of the invention are shown.
This invention may, however, be embodied in manydifferent
forms and should not be construed as limited to the embodi-
ments set forth herein; rather, these embodiments are pro-
vided so that this disclosure will be thorough and complete,
and will fully convey the scope of the invention to those
skilled in the art.
Abbreviations and Definitions
The following abbreviations are used throughout this
application: bp—basepairs; BT—Bacillus thuringiensis or
B. thuringiensis; BT-R,—BT toxin receptor of type x;
BBMV—brush border of the membrane vesicles; cONA—
complementary DNA; Cry toxin—parasporal crystalline
toxin of BT; IEF—immunoelectrophoresis; kb—kilobase or
kilo base pairs; kD—kilodaltons; K,,—dissociation constant;
LC,,—lethal concentration resulting in a 50% mortality;
PBW—pink bollworm, Pectinophora gossypiella or P. gos-
sypiella; PCR—polymerase chain reaction; RACE—Rapid
Amplification of cDNA Ends; RT—reverse transcriptase;
SW—silkworm (Bombyx mori or B. mori); THW—tobacco
hornworm (Manduca sexta or M. sexta); and UTR—un-
translated region.
The term “x % homology”refers to the extent to which
two nucleic acid or protein sequences are identical as
determined by BLAST homology alignmentas described by
T. A. Tatusova & T. L. Madden (1999), “Blast 2
sequences—a new tool for comparing protein and nucleotide
sequences”, FEMS Microsior Lett. 174:247—250 and using
the following parameters: Program (blastn) or (blastp) as
appropriate; matrix (OBLOSUM62), reward for match (1);
penalty for mismatch (-—2); open gap (5) and extension gap
(2) penalties; gap x-drop off (50); Expect (10); word size
(11); filter (off). An example of a web based two sequence
alignment program using these parameters is foundat http:/
www.ncbi.nlm.nih.gov/gorf/b12. html.
The invention thus includes nucleic acid or protein
sequences that are highly similar to the sequences of the
present invention, and include sequences of 80, 85, 90, 95
and 98% similarity to the sequences described herein.
The invention also includes nucleic acid sequences that
can be isolated from genomic or cDNAlibraries or prepared
synthetically, and that hybridize underhigh stringency to the
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entire length of a 400 nucleotide probe derived from the
nucleic acid sequences described herein under. High strin-
gency is defined as including a final wash of 0.2xSSC at a
temperature of 60° C. Underthe calculation:
Eff Tm=81.5+16.6(og M /Nat]}+0.41(% G+C)-
0.72(% formamide)
the percentage allowable mismatch of a gene with 50% GC
under these conditions is estimated to be about 12%.
The nucleic acid and protein sequences described herein
are listed for convenience as follows:
 
 
 
SEQ ID
Nos. DNA and Protein Sequences
SEQ ID BT-R2 cDNA sequence from P. gossypiella
NO: 1 (FIG. 1)
SEQ ID BT-R2 protein sequence for P. gossypiella
NO: 2 (FIG. 2)
SEQ ID
Nos. Primer Sequences Primer Name
SEQ ID 5' CAN ATH CGN GCN CAN GAY GGN BTR 1209U
NO: 3 GG 3'
SEQ ID 5' TTIG TAC ACS GCW GGS ATW TCC BTR 1355U
No: 4 Ac 3'
SEQ ID 5' NAC YTG RTC RAT RTT RCA NGT BTR 1486D
No: 5 CAT 3'
SEQ ID 5' NCC DAT NAG RTC NGA RTC RIT BTR 1657D
NO: 6 NGA 3'
SEQ ID 5' TAG GTT GTA TCC TCA GTA TGA PBW-BTR
NO: 7 GGA 3' GSP-1
SEQ ID '5' CCA GAG TGG AGT CCA CCG CCA PBW-BTR
No: 8 TA 3' GSP-2
SEQ ID 5' CTG AGT AAG TGT TAT CTT GAA PBW-BTR
NO: 9 AG 3' GSP-3
SEQ ID 5' CAN ATH CGN GCN CAN GAY GGN BTR 1209U
NO: 10 GG 3'
SEQ ID 5' GAT AGC GGC CCC AGG AAC CAA PBW-BTR
NO: 11 CAA ACA GG 3' GSP-4
SEQ ID 5' AGT GCG AGT GCT TTG AAT CTG PBW-B' IR
NO: 12 TGA 3' P2U
SEQ ID 5' GTC TCT TCT CAC CGT CAC TGT PBW-BTR
NO: 13 Cac T 3' P5U
SEQ ID 5' GCA TGC TGG CAG TAG GIT GTA PBW-BTR
No: 14 Tc 3' P6D
SEQ ID 5' GGC CAC GCG TCG ACT ACT AC 3' (AUAP)
No: 15
SEQ ID 5' GGC CAC GCG TCG ACT ACT ACT (AP)
NO: 16 TTT TTT TTT TIT TIT T 3'
N =A, C, T, or G}
H =A, T, or C;
B=T, C, or G;
D=A, T, or G;
V =A, C, or G;
R= A or G;
Y= C or T;
M =A or C;
K = T or G;
S =C or G;
W=Aort?T
Moreparticularly, the studies described herein weretar-
geted toward the identification, cloning and characterization
of novel Cry toxin receptors. One embodiment wasdirected
to characterization and isolation of the heretofore unidenti-
fied Cry toxin receptorof the pink bollworm, P. gossypiella,
hereinafter referred to as “PBW”.
In order to identify and isolate the Cry toxin receptor of
the PBW, toxicity was determined for five different Cry
proteins (CrylAa, CrylAb, CrylAc, Cry3A and Cry11A)
against neonate PBW larvae. It was determined that the
lepidopteran-specific toxins (CrylAa, Cry1Ab and CrylAc)
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showed high toxicity toward PBW larvae with a LCs,
ranging from 25-45 ng/cm* of insect diet, while the
coleopteran specific (Cry3A) or the dipteran specific
(Cry11A)toxins did not exhibit any detectable toxicity up to
2000 ng/em? (FIG. 3).
The binding of the three lepidopteran-specific CrylA
toxins (CrylAa, Cryl1Ab and CrylAc) to the BBMV of P
gossypiella was characterized in detail. Ligand blot experi-
ments showedthat proteins of 120 kD bind only the Cry1Ac
toxin whereas a 200 kD protein binds to CrylAa, Cry1Ab
and Cry1Actoxins.It is now knownthat the 120 kD protein
is a heat shock protein, although its relation to the Cry toxin
effect is not understood.
In the case of the 175 kD cadherin-like Cry1Aa binding
protein from Bombyx mori, '**I-labeled CrylAa binding
was eliminated by the presence of unlabeled CrylAa, but
additional band(s) of approximately 110 kD, identified by
'251-Cry1Aa ligandblots, failed to demonstrate a detectable
degree of competition. Thus, it was determined that P.
gossypiella, like M. sexta and B. mori, contains both high-
affinity and low-affinity binding proteins for at least one
Cry1A toxin and that the 200 kDa protein from PBW is a
common binding protein for the lepidopteran-specific
Cry1A toxins.
The detailed mechanism of the Cry1A toxin interaction
with the midgut BBMV of the pink bollworm was deter-
mined. The equilibrium dissociation constants (K,) calcu-
lated from the homologous competition assays (FIGS. 3A
and 3B) are 16.5, 12.4 and 12.8 nM andthe concentrations
of binding sites are 3.7, 3.6 and 8.6 pmol/mg, for CrylAa,
Cry1Ab and Cry1Ac, respectively. The Hill Coefficients for
the three Cry1A toxins are between 0.6 and 0.8 for BBMV
binding proteins (FIG. 3A), indicating that there is negative
cooperativity in the binding of these toxins to the binding
site(s) in the BBMV.Binding of the Cry1A toxins to BBMV
proteins was specific and saturable. The toxin amount
required for saturation of 460 ug of BBMV proteins was in
the following order: Cry]Ac>Cry1Aa>Cry1Ab.
Immunoprecipitation of BBMV proteins with anti-
CrylAb antiserum and subsequent ligand blotting with
'251-Cry1Ab toxin also showed binding of the toxin to an
approximately 200 kD protein. The 200 kD protein is a
single protein as shown by 2D-gel analysis (data not shown).
A comparison between the 210 kD binding protein from M.
sexta with a pI ~4.3 and the 200 kD binding protein from P
gossypiella (p] ~4.1) revealed that both proteins have almost
the samepI. It was determinedthat the 200 kD PBWprotein
had somecross-reactivity with polyclonal antisera against
the M. sexta BT-R, 210 kD protein.
In order to clone the PBW BT-R,gene, fully degenerate
primers were designed based on the conserved amino acid
sequences between that of the two receptors, tobacco horn-
worm (“THW”) BT-R, and silkworm (“SW”) BT-R175. The
primer locations were designed to include or exclude a
sequence thoughtby the present inventors to encode a region
in the extracellular domain critical to toxin binding, herein
after “READ”signature sequence. Hereinafter this binding
fragment of the DNA sequence will be referred to as the
“signature” region.
Three clones were obtained, PBW-421 (aa 1367-1496),
PBW-866 (aa 1210-1496) and PBW-1373 (aa 1210-1675),
which have about 50% nucleotide and about 60% amino
acid sequence similarity to both THW BT-R, and SW
BT-R175. The 421 bp and 866 bp clones encode proteins of
about 21 and 32 kD, respectively. Although both expressed
proteins cross-reacted with THW BT-R,polyclonalantisera,
the 32 kD protein, but not the 21 kD protein, was shown to
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bind Cry1Ab toxin specifically with high affinity. The esti-
mated K,, value is about 17 nM,whichis similar to the K,
value obtained for BBMV. Similarly, an internal fragment
from the PBW-866 clone did not bind toxin, but did cross-
react with BT-R, antibodies. This data demonstrates that
recognition by anti-BT-R, antibodies is insufficient to define
a functional toxin receptor.
In order to obtain a cDNA sequence encoding the full-
length receptor, the 5' and 3' ends of the PBW BT-R,
receptor were first obtained using 5' and 3' RACEreactions
followed by cloning ofthe full-length receptor cDNA using
genespecific primers from the 5' and 3' UTR.Thefull-length
cDNAclone (SEQ ID NO: 1) has an open reading frame of
1729 aminoacids (SEQ ID NO:2), with a deduced molecular
weight of 194 kD and a calculated pI value of 4.1, whichis
similar to the value determined by 2-D gel analysis.
The protein consists of three domains: extracellular, trans-
membrane and cytoplasmic. The protein sequence contains
two hydrophobic regions, one at the amino terminus, char-
acteristic of a signal peptide and one near the COOH-
terminus (amino acids 1575-1600) that probably forms a
transmembrane domain. The extracellular domain contains
12 cadherin-like motifs, in addition to, a membrane proxi-
mal region that contains two leucine zipper motifs. Eleven
consensussites for N-linked glycosylation are present in the
extracellular region, which may account for the difference in
apparent molecular mass between the native protein and the
calculated mass.
Basedonthe results discussed above,it would be apparent
to one of ordinary skill in the art that variances in receptor
sequencesor in toxin binding affinities or in receptor expres-
sion may render different levels of toxin susceptibility or
resistance. Furthermore, the receptor of the present inven-
tion may be used to generate transgenic organisms by
methods well known in the art.
To investigate the mode of action of BT toxin, a mam-
malian heterologous cell culture system was chosen for
several reasons. First, BT Cry1A toxins have shown no toxic
effect on any mammalian cell lines studied to date. This
characteristic is in contrast to most available insectcell lines,
which exhibit variable degrees of sensitivity to toxin (Kwa
et al., 1998). Second, the use of a mammalian cell would
allow the determination of whether the receptor, indepen-
dent of any associated protein in an insect cell line, would
mediate toxicity.
When introduced into mammalian COS-7 cells, the
cloned cDNAexpressed BT-R, that was detected by western
blot analysis using BT-R, antisera. The expressed receptor
was displayed on the cell surface and detected with poly-
clonal antibodies raised against M. sexta BT-R,. These
results suggest that the protein expressed by the PBW BT-R,
cDNAis similar to the natural protein found in the insect
midgut.
The possibility of using COS-7 mammalian cells trans-
fected with a receptor for BT toxins as a model system for
assessing the cytotoxicity of the Cry1A toxin was deter-
mined. The surface receptor clearly was able to bind to the
Cry1Ab toxin, which was detected by immunofluorescent
labeling using Cry1Ab antibodies (data not shown). These
results indicate that the binding site of the receptor must
assume its native conformation. Significantly, intensively
labeled vesicles in the methanol fixed transfected COS-7
cells were observed when the cells were incubated with
BIT-R,antiserum (data not shown). This observation indi-
cates that vesicles, which form normally in the cell endocy-
tosis/exocytosis pathway, contain the BT-R, proteins. In
addition, this result shows that the receptor is not only
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expressed on the cell surface, like its native counter part in
the insect midgut, but also is recycled normally by thecell.
Microscopy of the transfected COS-7 cells treated with
Cry1Ab toxins for various times demonstrated significant
cytopathological patterns. The cytopathological changes
observed under the fluorescent microscopeincluded disrup-
tion of the plasma membrane, cell swelling, disintegration
and death of the cells. The symptoms were obtained in the
presence of 0.6 ug/ml CrylAb for 2 hr. In contrast, no
cytopathological effects were revealed for cells transfected
with vector alone and subsequently treated with toxin.
Clearly, there is a distinct correlation between toxin binding
to the surface receptor and toxicity to the cells.
The cytological appearance and ultrastructure of the mid-
gut cells of M. sexta and other lepidopteran larvae, after
intoxication with preparations of BT, have been reported
extensively by several authors (Bravoet al., 1992). Histo-
pathological studies on M. sexta midgut demonstrated
pathological behavior for Cry1A on midgut epithelial cells
(columnar cells) (Midhoe et al., 1999). These investigators
demonstrated that the epithelial cells of the midgut swell
shortly after ingestion of the BT toxin. Eventually, the
epithelial cells burst and released their cytoplasmic contents
into the midgut lumen.
The present observations on the intoxicated transfected
COS-7 cells are in complete agreement with these reports,
which demonstrates that the toxin acts similarly in both
systems. Furthermore, it should be apparent to one of
ordinary skill in the art that cells expressing transfected
molecules of the BT toxin receptor as well as cells express-
ing a natural form of the receptor may be used to asses the
level of cytotoxicity and mode ofaction of toxins.
Lepidopteran insects generally express high molecular
weight binding proteins for the Cry1A toxins that range in
size from 160 to 220 kD (Martinez-Ramirez 1994; Vadla-
mudi et al.; 1993, Oddouet al., 1993; Nagamatsu et al.,
1998a; Ihara et al., 1998). Two ofthese proteins, in addition
to the 200 kD pink bollworm receptor, have been cloned and
sequenced: the BT-R, 210 kD cadherin-related receptor
from M. sexta (Vadlamudi et al., 1995) and the 175 kD
cadherin-related from B. mori (Nagamatsu et al., 1998a).
Interestingly, these two proteins have 60-70% identity and
80% similarity between themselves.
P. gossypiella expresses a high-affinity and a low-affinity
binding protein for at least one Cry1A toxin, CrylAc. The
high-affinity receptor is a cadherin-related protein with a
large molecular mass. One of the most important conserved
regions may be the signature sequence. The signature
sequence contains the sequence (READ), which is believed
to be responsible for toxin binding due to the presence of
two negatively charged amino acids that bind to two argin-
ines in the toxin binding site. Supporting evidence comes
from the immunoblot analysis for clones PBW-866, which
contains the proposed signature sequence, and PBW-421,
which does not include the signature sequence. To further
define the minimum binding fragment, truncation peptides
were tested for their ability to bind toxin (FIG. 4). The
minimum binding fragment contains the “READ”signature
sequence and consists of amino acids 1269 to 1367.
The information provided herein is necessary for under-
standing the molecular biology of the toxin receptor in the
pink bollworm and to engineer more effective toxins in
terms of longer persistence in the field, higher toxicity, and
preclusion of resistance development. This information will
facilitate understanding of Cry toxin receptor interactions in
other economically important insect crop pests.
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EXAMPLE1
Specificity of Purified Toxins
Recombinant protoxins CrylAa, CrylAb, and CrylAc
(Bacillus Genetic Stock Center, Ohio State University) were
prepared from £. coli JM-103 and trypsinized essentially as
described by Lee et al. J. Biol. Chem. (1992) 267: 3115. In
addition, the soluble trypsinized 60 kD toxins were sub-
jected to FPLC NaCl salt gradient purification over an
HR-5/5 Mono-Q anion exchange column (PHARMA-
CIA™) prior to quantitation, radio-iodination, and use in
bioassays. Cry3A crystal protein from B. thuringiensis
subsp. tenebrionis was solubilized in 3.3 M NaBr and
treated with papain, and the resulting 67 kD toxin was
purified by the method of Li et al. Nature (1991) 353: 815.
The 65 kD Cry11A toxin wasisolated from B. thuringiensis
subsp. israelensis via solubilization as described by Chilcott
et al. J. Gen. Micro (1988) 134: 1551 and further purified by
anion-exchange FPLC.All toxin protein quantitations were
performed using the bicinchoninic acid method (PIERCE
CHEMICAL™)with Bovine Serum Albumin (BSA, Frac-
tion V) as a standard.
Pink bollworms were obtained from the USDA PINK
BOLLWORM REARING FACILITY™ (PBWREF,Phoenix,
Ariz.). An artificial diet was obtained from SOUTHLAND
PRODUCTS INC.™, Lake Village, Ariz. The diet was
reconstituted in boiling water and cooled to 55° C. Each Cry
toxin was thoroughly mixed in the warm liquid diet and
bioassay cups werefilled with 20 ml of diet. After cooling
and drying, 10 neonate larvae were placed in each cup and
the cups were immediately capped. The method of Watson,
et al., Beltwide Cotton Conference, Memphis, Tenn. (1995)
was used to determine the toxicity of trypsin-activated
toxins against first-instar larvae of P. gossypiella. Generally,
fourreplicates of six cups were prepared for each dose. Cups
were incubated at 30° C. for 21 days, the length of time
necessary for more than 95% of normal P. gossypiella to
reach pupation. At the end of 21 days, the diet cups were
examined and the numbers of larvae and numbers of pupae
or adults in each cup were recorded.
The specific toxicities of purified CrylAa, Cry1lAb,
CrylAc, Cry3A and Cry 2A tested using neonate P. gossyp-
iella larvae are shown in FIG.3B.It was determinedthat all
three Cry1A toxins are highly toxic, with LC,, values
ranging from 25-45 ng/cm? ofartificial diet. Cry3A (con-
sidered toxic to coleopteran or beetle insects) and Cry IIA
(considered toxic to dipteran insects, especially mosquitoes)
were not toxic to P. gossypiella larvae at the highest con-
centrations tested (2000 ng/cm*)
EXAMPLE 2
Characterization of the BT-R, Receptor
Early fourth-instar larvae were kept on ice for 1 hr and
midguts were surgically removed from the larvae. BBMW
were prepared from midgut tissues by the differential mag-
nesium precipitation method of Wolfersberger, et al., Comp.
Biochem. Physiol. (1987) 86A: 30, in the presence of
protease inhibitors (5 mg/ml pepstatin, antipain, aprotonin,
leupeptin, 1 mM PMSF, and 5 mM benzamidine). Thefinal
pellet was resuspendedin bufferA (300 mM mannitol, 5 mM
EGTA, and 17 mM Tris-HCl, pH 7.5) containing the pro-
tease inhibitors, flash frozen in liquid nitrogen, and stored at
-85° C.
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Cry toxins were radioiodinated using the chloramine T
method (Hunter and Greenwood, Nature (1962) 194: 495,
with 1?°I—Na (NEN DUPONT™). Ten ug of toxin were
mixed with 5 ul of '?°I—Na (0.5 mCi) in 100 pl ofNaHPO,
buffer (0.5 M, pH 7.4) with 25 ul of Chloramine T (4
mg/ml). The reaction mixture was agitated for 20-25 sec-
ondsat 23° C. and the reaction was stopped by adding 50 ul
of Na,S,O, (4.4 mg/ml). Free iodine was removed by gel
filtration on an EXCELLULOSE™ desalting column
(PIERCE™) equilibrated with PBS containing 10 mg/ml
BSA.
Toxin Binding Assays.
Both homologous and heterologous competition inhibi-
tion binding assays were performed as described by Keeton
and Bulla (1997). A total of 25 ug ofBBMV were incubated
with 1.2 nM '?°I-Cry1 Actoxin in the presence of increasing
concentrations (0O-1000 nM) of the appropriate unlabeled
homologous toxin (CrylAc) or heterologous toxins
(CrylAa, Cry1Ab, Cry3A, and Cry11A). Incubations were
in 100 wl of binding buffer (PBS/0.2% BSA)at 25° C. for 30
min. Radiolabeled and unlabeled toxins were mixed together
before adding them to the BBMV. Unbound toxins were
separated from BBMV-bound toxin by centrifugation at
14,000xg for 10 min. The pellet containing bound toxin was
washed three times in ice cold binding buffer by gentle
vortexing and radioactivity in the final pellet was measured
using a BECKMAN GAMMA5500™counter. Binding data
were analyzed by the PRISM™ program (GRAPHPAD
SOFTWAREINC.™,San Diego).
Competition inhibition binding of !?°I-Cry1Ac toxin to P
gossypiella was carried out in the presence of increasing
concentrations of unlabeled CrylAc, CrylAb, CrylAa,
Cry3A and Cry11A toxins. Homologous competition bind-
ing assays were performed with iodinated Cry1A toxins and
various concentrations ofthe corresponding unlabeled toxin.
The binding site concentration (B,,,,), and dissociation
constant (K,,) of labeled toxins were calculated from three
separate experiments. The equilibrium binding parameters
were estimated by analyzing the data with the PRISM™
computer program.
Radioligand Blotting.
The two hundred ug of BBMWproteins were solubilized,
separated by 7.5% SDS-PAGEand transferred to polyvi-
nylidene difluoride (PVDF) membrane as described by
Francis and Bulla (1997). Blots were blocked with TBS (10
mM Tris-HCI and 0.9% NaCl) containing 5% non-fat dry
milk powder, 5% glycerol 0.5% Tween-20, and 0.025%
sodium azide for 2 hr at 25° C. Blocking buffer was removed
and membranes were incubated for 2 hr at 25° C. in an equal
volume of fresh blocking buffer containing 2x10° cpm/ml
(1-1.25 nM)of '*°I-Cry1A toxinseither in the presence or
absence of unlabeled toxins. Finally, membranes were
washed three times with fresh blocking buffer for 10 min
each, rinsed once with TBS, dried, and exposed to Kodak
X-ray film at -80° C.
To determinethe specificity of binding to the 200 and 120
kD proteins, blots of PBW BBMVproteins was incubated
with '?°1-CrylAc toxin in the presence of increasing con-
centrations of unlabeled CrylAc toxin.
Immunoprecipitation of CrylAb Binding Protein.
Immunoprecipitation was carried out according to Vadla-
mudi, et al. (1993). Twenty five ul of Cry 1Ab antiserum
were added to 1 ml of protein A-Sepharose CL-4B equili-
brated in washing buffer (1% Nonidet P-40, 6 mM EDTA,
50 mM Tris-HCl and 250 mM NaCl) and mixed for 1 hr at
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4° C. After washingthe blot three times with washing buffer,
700 wg of Cry 1Ab toxin were added and the mixture were
incubated for an additional 1 hr at 4° C. and washed again
three times with washing buffer. Pink bollworm BBMV
proteins (6 mg) were solubilized in washing buffer contain-
ing 1% NP-40 and protease inhibitors (10 ug/ml pepstatin,
antipain, aprotonin and leupeptin; 5 mM iodoacetamide; and
1 mM PMSF). Unsolubilized proteins were removed by
centrifugation. Solubilized proteins were filtered through a
0.45 um filter, added to 1 ml of Sepharose-protein A beads
linked to Cry1Ab toxins, and the sample wasstirred gently
for 1 hr at 4° C. Sepharose beads were centrifuged and
washed four times with washing buffer containing 0.25%
NP-40 and 0.02% SDS. The toxin-binding protein complex
wasdissociated by heating in Laemmli (1970) sample buffer
and the binding proteins were Coomassie stained and
detected by ligand blotting with 125I-Cry1Ab and Western
blot using Cry1Ab antiserum.
Immunodetection of Pink Bollworm Cry1A Receptor.
Immunoprecipitated proteins were transferred to a PVDF
membrane, blocked with 5% nonfat dry milk in PBS buffer
and incubated at 4° C. overnight in the same blocking buffer
containing 10 ug/ml of Cry1Ab. Unbound toxin was washed
with PBS. Antibodies raised in rabbits against the 60 kD
Cry1Ab toxin were diluted 1:1000 and hybridized to the
membrane for 2 hr at 25° C. and the blot then was washed
with PBS. Peroxidase-conjugated goat anti-rabbit IgG was
diluted 1:3000 in TBS blocking buffer and hybridized to the
membrane for 2 hr. The membrane then was washed exten-
sively with PBS. Visualization of the bound toxin was
accomplished using the Enhanced Chemiluminescence
(ECL) Western blotting detection method (AMER-
SHAM™),.
Southern Blot Analysis.
Forty ug of PvuH digested genomic DNA from P. gos-
sypiella or M. sexta were separated on a 0.8% 1x TBE-
agarose gel and blotted onto a nylon membrane (BIO-
RAD™, ZETA-PROBE GT™). The analysis was carried
out according to Sambrook, et al. Molecular Cloning: A
Laboratory Manual, 2" Ed. Cold Spring Harbor Labora-
tory, N.Y. (1989). Thefilter was hybridized with >*P-labeled,
random primed, C-terminal of BT-R, cDNA (HincH frag-
ment, 0.5 kb). Filter hybridization was carried out at 42° C.
for 21 hr in 50% formamide, 5x Denhardt’s reagent, 1M
NaCl, 2% SDS, 50 mM Tris-HCI and 100 ug/ml of salmon
sperm DNA.Thefilter was washed with 2xSSC, 0.5% SDS,
then with 1xSSC, 0.5% SDS, then with 0.5xSSC, 0.5%
SDS,followed by a fourth wash with 0.25xSSC, 0.5% SDS.
Each wash was for 30 min at 42° C. Finally, the filter was
rinsed in 2xSSC and exposed to Kodak X-ray film at -85°
C.
Electrophoretic Elution of Proteins.
Electrophoresis was performed in 1.5-mm-thick poly-
acrylamide slab gels using 7.5% acrylamide (pH 8.0). After
SDS-PAGE, proteins were revealed as transparent bands
with 4 M sodium acetate solution. The proteins were excised
using a razor blade. Proteins in the gel strips were fixed in
50% (v/v) methanol solution for 15 min and equilibrated
twice in 0.125 M Tris-HCI buffer (pH 6.8) and 2% 2-mer-
captoethanol for an additional 15 min. Equilibration of the
gel strips in the above buffer with 1% (w/v) SDS was
performed as described above. The equilibrated gel strips
were inserted into a dialysis tube with a minimum amountof
the buffer containing SDS (25 mM Tris, 190 mM glycine
and 0.1% SDS). Electroelution was carried out essentially as
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described by Findlay (1990). A horizontal flat-bed mini-gel
electrophoresis apparatus (BIO-RAD™)wasusedfor elec-
troelution at 50 V for 12 hr at 4° C. The buffer consisted of
25 mm Tris, 190 mM glycine and 0.1% SDS (pH 8.3). At the
end of electrophoresis, the polarity of electrodes was
changed for 30 sec to avoid adsorption of proteins onto the
dialysis tubes. The buffer inside the dialysis tubes was
collected and the tubes were washed three times with a
minimum volume of buffer. SDS was dialyzed out and
protein was concentrated by using a CENTRICON-30
micro-concentrator (AMICON).
Two-Dimensional Gel Electrophoresis.
Two-dimensional gel electrophoresis was performed
according to the method of O’Farrell (1975). Isoelectric
focusing was carried out in 2.0 mm (I.D.) glass tubes using
2.0% ampholines (pH 3.5-10; LKB/PHARMACIA™)for
9600 volt-hr. After equilibration for 10 min in buffer ‘O’,
tube gels were applied to the stacking gels on top of 8%
acrylamide (pH 8.0) slab gels (14x14 cm). SDS slab gel
electrophoresis was carried out for 4 hr at 12.5 mA. After
electrophoresis, one gel was stained with Coomassie blue
and the others were transblotted onto PVDFpaper overnight
at 200 mA (Vadlamudiet al., 1993). The PVDF paper was
blocked with powdered milk solution, incubated with !*°I-
CrylAc or 17°]-Cry1Ab and exposed to X-ray film at -85°
C.
Identification and Recovery of cDNA Encoding BT-R,.
Total RNA wasprepared from the midgut tissue of fourth
instar larvae of the PBW by the guanidinium thiocyanate
method (Chomezynki et al. Analyt. Biochem. (1987) 162:
156). Poly (A+) RNA wasisolated with the POLYATRACT
MRNA ISOLATION SYSTEM™ (PROMEGA™), First
strand cDNA wassynthesized using oligo-(dT) and random
hexamer primers and reverse transcriptase according to
standard methodologies and used as the template for ampli-
fication by polymerase chain reaction (PCR) of desired
mRNAs. Degenerate oligonucleotide primers were designed
based on the conserved amnio acids between M. sexta BT-R,
and B. mori BT-R175. Such primers were used to clone
partial fragments of PBW BT-R,.
For cloning of the PBW BT-R,, RT-PCR was employed
using fully degenerate oligonucleotide primers derived from
a sequence in the membrane proximal domain conserved
sequence between M sexta BT-R, and B. mori BT-R175.
Primers BT-R-1355U and BT-R-1209U against BT-R-
1486D were applied to PBW cDNAto amplify 421-bp and
866-bp fragments. The PCR products were resolved on 1.5%
agarose, gel purified, cloned into a TA cloning vector
(INVITROGEN™)and transformed into F. coli INV«F.
The presence and identity of the correct insert was con-
firmed with EcoR1 digestion and DNA sequencing. The
PBW-886 clone was found to contain the nucleotide
sequence found in clone PBW-421. In addition, primer
1209U against 1657D was used to clone a 1373-bp fragment
(PBW-1373), which represents most ofthe membraneproxi-
mal domain and the cytoplasmic domain. Clone PBW-287
(aa 1346-1438) is a 287 bp internal fragment from 866-bp
clone and wascloned using gene specific primers P5 and P6.
Based on the sequence obtained from the partial clones,
sense and antisense primers were used to clone the 3' and 5'
ends of the PBW BT-R,clone by the 5' and 3' RACE system
according to the manufacturer’s instructions (GIBCO
BRL™). The 5' end was amplified using gene-specific
antisense primers GSP1, GSP2 and GSP3 against
ABRIDGED UNIVERSAL AMPLIFICATION PRIMER™
(AUAP™)provided in the kit. The 3' end was amplified
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using gene primer GSP4 against AUAP™. The PCR product
of the predicted size was isolated and subcloned into TA
cloning vector pCR2.1 (UNVITROGEN™)and transferred
into £. coli INV«F. For recombinant protein expression in
E. coli, or COS7cells, the coding sequences for the RT-PCR
clones or the full length PBW-BT-R, clone were recloned
into the pET30 or pcDNA3.1 expression vectors and trans-
formed into BL21 (DE3) LysS (NOVAGEN™) or COS7
mammalian cells. The £. co/i cultures were induced using a
1 mM final concentration of IPTG for 3 hr.
The full length PBW BT-R, (~5.5 kb; see sequence in
FIG. 1 SEQ ID NO:1) was ligated into the mammalian
expression vector pcDNA3.1 UNVITROGEN™)and con-
firmed by DNA sequencing. The molecular mass of the
deduced polypeptide is 194 kD with a pI of 4.1. The receptor
has an open reading frame of 1729 amino acids (FIG. 2)
(SEQ ID NO: 2). The amino acid sequence contains a
putative signal peptide of 23 amino acid residues, a trans-
membrane domain of 27 residues (aa 1578-1605) and a
124-residue cytoplasmic domain.In addition, the amino acid
sequence contains 12 putative cadherin motifs, 11 putative
N-glycosylation sites and two leucin zipper motifs at amino
acid 1541-1562 and 1578-1600. The minimum toxin bind-
ing fragment is amino acids 1269 to 1367 (FIG.4).
When the protein homology is analyzed by BLASTP, as
described under definitions above, the closest paralog in the
GenBank nonredundant (nr) database is the Bombyx mori
receptor at Acc. No. JE0128 with Identities=1034/1708
(60%), Positives=1266/1708 (73%), Gaps=35/1708 (2%).
The next closest species was Manduca sexta at Acc. No.
AAB33758.1 with Identities=871/1540 (56%), Posi-
tives=1101/1540 (70%), Gaps=22/1540 (1%). The nucle-
otide sequence showed nosignificant homologies.
The peptide homologies amongst these three species are
shown in FIGS. 5A-C where perfectly conserved residues
are boxed. Peptide fragments of the SBW sequence may be
used to generate specific or nonspecific antibodies. Usually,
it is recommended that at least 17 amino acid peptide
fragments are used to generate antibodies, however, smaller
peptides may also be antigenic and sufficiently complex to
be unique. In particular, the carboxyl tail (aa 1677-end) of
the PBW sequenceis unique to this species and can be used
to generate PBW unique antibodies. Exemplary peptides
that may be useful as antigens (numbered with respect to
FIG. 5, SEQ ID NO:2) are shown as follows:
 
PBW Unique Peptides CommonPeptides
aa 534-544 aa 291-304
aa 697-705 aa 622-632
aa 886-895 aa 791-803
aa 1055-1066
aa 1321-1331
aa 1451-1461
aa 1516-1525
aa 1572-1582
aa 1677-1729
aa 1621-1642
 
Immunodetection of the Expressed BT-R, Proteins.
Cell lysates from the induced BL21 (DE3) LysSbacterial
cultures were electrophoresed and transferred to PVDF
membranes. Filters were blocked at 4° C. in 50 ml of
blocking buffer containing 10 ug/ml of Cry1Ab toxin.
Unbound toxin was removed by PBS. Rabbit primary anti-
bodies for the THW was removed by PBS. Rabbit primary
antibodies for the THW BT-R, extracellular domain or for
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the FPLC-purified Cry1Ab were diluted 1:1000 in 50 ml
TBSblocking buffer. Thefilters were incubated for 2 hr with
the antiserum and washed three times with the blocking
buffer. Peroxidase-conjugated goat anti-rabbit IgG was
diluted to 1:2000 and incubated with filters for 2 hr at 27° C.
and was developed with the enhanced chemoluminescence
(ECL) detection system (AMERSHAM™),
Mammalian Expression of BT-R,.
The PBW BT-R, cDNA cloned into pcDNA3.1, a mam-
malian expression vector (NVITROGEN™), was
expressed in mammalian cells (COS-7 SV40 transformed
African green monkey cells; ATCC CRL-1651) according to
methods described by Keeton and Bulla, Appl. Environ.
Microbiol. (1997) 63: 3419. COS-7 cells (4x10*/well) were
grown in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% heat-inactivated fetal bovine serum
(FBS) on 12 mm coverslips placed in a 24-well plate.
COS-7 cells were transfected with the construct using the
LIPOFECTAMIN PLUS REAGENT™ (GIBCO BRL™),.
The cells were incubated for two days at 37° C. in DMEM
medium containing 10% FBS in a humidified atmosphere of
10% CO,. BT-R, was monitored by SDS-PAGE and immu-
noblotting with anti-BT-R, or antiCry1Ab antiserum. Sur-
face expression was detected by immunofluorescence
microscopy with the anti-BT-R, antibodies. The effects of
BT toxin on the transfected cells were demonstrated by
incubating the cells in the presence or absence of Cry1Ab
toxin for 2 or 4 hr and monitoring the morphological
changes by immunofluorescence microscopy using either
anti-BT-R, or anti-Cry1Ab antibodies. Cell death is clearly
demonstrated (not shown).
Immunofilourescene Microscopy.
COS-7 cells were grown on 12-mm glass coverslips in a
24-well plate. The cells were fixed and permeabilized either
in cold methanol (-20° C.) or 4% paraformaldhyde for 15
minutes at 27° C. Coverslips were rinsed three times with
PBSand then blocked for 15 minutes with 1% BSA in PBS.
Cells were incubated with primary antibody for 30 minutes
at 27° C. followed by rinsing and blocking as just described.
The same incubation and washing procedures were applied
to secondary antibody. Antibodies were detected with
TRITC goat anti-rabbit IgG. Coverslips were mounted in
FLUROMOUNT G™and viewed with an OLYMPUS™
microscope equipped with epi-fluorescenceillumination and
a 40x Apochromat lens. Photography was done with an
OLYMPUS SPOT™camera.
Western Blot Analysis.
Transfected COS-7 cells were washed with cold PBS,
lysed in lysis buffer (50 mM Tris/HCL, 1 mM EDTA, 10 uM
leupeptin) and resuspended on ice for 10 minutes. Then, 4x
sample buffer was addedto the cells and heated at 95° C.for
5 minutes. Lysates were subjected to electrophoresis through
7.5% SDS-PAGE, and proteins were electrophoretically
transferred to a PVDFfilter, blocked and incubated with
either anti-BT-R,, or anti-Cry1Ab antibodies.
Results: Identification of '**I-Cry1A Binding Proteins.
BBMVproteins ofP. gossypiella ranged in molecularsize
from greater than 205 kD to less than 25 kD (data not shown)
as determined by SDS-PAGE.'*°]-labeled CrylAa, Cry1Ab
and CrylAc were used in ligand blots to identify which P.
gossypiella BBMVproteins bind the respective toxins. Pro-
teins that had been separated by SDS-PAGE weretrans-
ferred to PVDF membranes and incubated with each radio-
labeled-toxin separately. 17°I-CrylAa, 1?°I-CrylAb and
'251-CrylAc boundto a protein of about 200 kD (data not
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shown). ‘?°I-CrylAc boundalsoto a protein bandat about
120 kD. Neither Cry1Aa nor Cry1Ab boundto the 120 kD
protein. The binding patterns for all three toxins were the
same under both reducing and nonreducing conditions (data
not shown).
Results: Competition Inhibition Binding Assays.
1251-labeled CrylAa, Cryl Ab and CrylAc were used in
binding assays with P. gossypiella BBMV. Competition
binding of '*°I-Cry1Ac toxin to P. gossypiella was carried
out in the presence of increasing concentrations of unlabeled
Cry1Aa, Cry1Ab, Cry1Ac, Cry3A and Cry11A toxins. Fifty-
percent inhibition ofCry1Ac binding was observed at 10 nM
of unlabeled CrylAc, 100 nM unlabeled Cry1Aa and 100
nM of unlabeled Cry1Ab. At a concentration of 1000 nm,
unlabeled CrylAc, Cry1Ab and Cry1Aa reduced binding of
iodinated Cry1Ac by 95, 82 and 80%, respectively (data not
shown). Neither Cry3A nor Cry11A toxin competed for the
Cry1Ac toxin bindingsite.
Homologous competition binding assays were performed
with iodinated Cry1A toxins and various concentrations of
the corresponding unlabeled toxin CrylAa, CrylAb and
Cry1Ac showedhigh binding affinity to BBW proteins (data
not shown). Fifty-percent inhibition of binding of CrylA
toxins was observed at concentrations of approximately 10
nM of the corresponding unlabeled toxin. These data indi-
cate that each of the three toxins binds specifically with high
affinity. The binding site concentration, B,,,,, and the dis-
sociation constant, Kj, of each toxin was calculated from the
three separate homologous competition inhibition experi-
ments by analyzing the data with the GRAPHAD computer
program (Table 1). The K, values all were similar and in the
low nM range whereasthe B,,,,,, for Cry]Ac was higher than
CrylAa or CrylAb. The Hill coefficients for CrylAa,
Cry1Ab and Cry1Acwere 0.65, 0.65, and 0.77, respectively,
indicating a negative binding cooperativity for the toxins
against the BBMV proteins. A single binding site model was
indicated based on the nonlinear regression analysis for both
CrylAa and Cry1Ab. Significantly, CrylAc, the data was
best accommodated by a two binding site model with high-
and low-affinity bindingsites.
Results: Specificity of '?°I-Cry]Ac Toxin Binding in Ligand
Blots.
In view of the putative “two-binding site” model pre-
dicted for the Cry1Ac toxin, radioligand blots of P. gossyp-
iella BBMV proteins were carried out with '*°I-Cry1lAc
toxin in the presence of increasing concentrations of unla-
beled CrylAc toxin. Autoradiography of these blots
revealed significant reduction in the intensity of the 200 kD
band (data not shown). Indeed, it was undetectable at a
Cry1Ac toxin concentration of 10 nM.In the case of the 120
kD band, however, there was virtually no reduction in the
band intensity (data not shown) even at a CrylAc concen-
tration of 1000 nM.In saturation binding assays, incubation
of a fixed amount of each of the three '?*I-labeled CrylA
toxins with increasing concentrations ofBBMV showedthat
binding reached a saturation level in each case but that the
level of Cry1Ac binding wassubstantially higher than those
of Cry1Aa and Cry1Ab. Maximum saturable binding at 400
ug/ml of BBMV was approximately 0.35, 0.05 and 1.5 ng
for Cry1Aa, Cry1Ab and Cry1lAc, respectively, which rep-
resents an approximately 30-fold difference in Cry1Ac bind-
ing compared to Cry1 Ab,and,it is 4 fold higher for CrylAc
compared to Cry1Aa (data not shown).
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Results: Immunoprecipitation of the CrylAb Binding Pro-
tein.
Immunoprecipitation experiments were performed using
Cry1Ab, which has the highest binding affinity of the three
toxins, to further examine the specificity of binding of the
toxin to the 200 kD protein. BBMV proteins were solubi-
lized in 1% NONIDET P-40™ and immunoprecipitated
with anti-toxin-protein A-Sepharose beads. The mixture of
bound material was solubilized in SDS sample buffer con-
taining 2-mercaptoethanol. Electrophoresis and staining of
the gel with Coomassie blue revealed a protein of about 200
kDa, demonstrating selective precipitation of the 200 kD
toxin-binding protein. Radioligand blotting with ‘°I-
Cry1Ab showed a band of about 200 kDa (data not shown),
indicating precipitation of the same binding protein as that
identified in previous ligand blot experiments. Additionally,
a Western blot (data not shown) of the immunoprecipitated
protein using CrylAb and anti-CrylAb polyclonal antise-
rum confirmedthe results of the radio-ligand blot (data not
shown). The low-molecular weight bands at 60 and 52 kDa
correspond to the Cry1Ab toxin and the heavy chain of IgG,
respectively.
Results: Purification of the Binding Proteins.
To determine whether the 200 kD band contains more
than one protein, the band was excised from a 7.5% SDS
polyacrylamide gel, electroeluted, dialyzed and concen-
trated. The concentrated protein was analyzed by two-
dimensional gel electrophoresis over a pH range of 3.5-10.
The protein migrated as one spot with an estimated pl of
4.5+0.2 and apparent molecular mass of 200 kDa. The
purified 200 kD protein stained with Schiffs reagent (data
not shown) indicating that the binding protein is glycosy-
lated. The 200 kD IEF spot bound 17*I-Cry1Ab (data not
shown) corroborates the results from other immunoprecipi-
tation studies.
Results: Southern Blot Analysis.
To detect the presence of the CrylA receptor in P
gossypiella, genomic DNA from both insects were hybrid-
ized against the cloned THW BT-R, cDNAandits 507-bp
minimum binding fragment. The two probes bound inten-
sively to the PvuH fragment ofM. sexta genomic DNA (data
not shown). There was weak hybridization to the P. gossyp-
iella DNA, however, using the minimum binding probe and
none with the full-length BT-R, probe (data not shown).
These results suggest that the minimum binding fragment
from M. sexta shares a significant level of nucleotide simi-
larity to the Cry1A binding receptor in P. gossypiella, more
so than to the full-length BT-R, receptor.
Results: Immunodetection of Native and Cloned PBW BT-
R, Using BT-R, Antibodies.
To confirm the relatedness ofthe cloned PBW fragmentto
the THW BT-R,andits ability to bind toxin, it was sub-
cloned into a pET30 expression vector. The native PBW
BBMV proteins and the expressed proteins from clones
PBW-287, -421 and -866 were resolved by SDS-PAGE,
transferred to a PVDF membrane and incubated with either
anti-BT-R, serum or Cry1Ab toxin followed by antiserum to
the toxin. The results reveal that BBMV contain a 200 kD
protein that interacts with THW BT-R,antiserum (data not
shown). In addition, clones PBW-287, -421 and -866 which
express proteins of about 15, 21 and 32 kD, respectively,
also cross-reacted with BT-R, antiserum. The 32 kD clone,
however, was the only protein to bind toxin, whereas no
detectable binding was observed with the 21 kD protein
(data not shown). These results confirm the sequencerelat-
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edness of PBW BT-R, to THW BT-R,and demonstrate that
the 32 kD protein contains the toxin-binding site of the
receptor.
Results: Specificity of Toxin Binding to the Cloned Recep-
tor.
The specificity and affinity of toxin binding to the receptor
fragment (PBW-866) was determined using competition
ligand blot analysis. The expressed 32 kD protein was
transferred to PVDF membranes and incubated with ‘*°I-
Cry1Ab in the absence or presence of increasing concen-
trations of unlabeled CrylAb toxin. Autoradiography
revealed significant reduction in the intensity of the 32 kD
band to an undetectable level in the presence of 500 nM
unlabeled Cry1Ab toxin (data not shown). Bound !7°] toxin
was quantitated with a gamma counter and the BIO-RAD
IMAGER™analysis system was used to calculate the
binding affinity of toxin to the expressed fragment. The
binding affinity (~17 nM) of the toxin was similar to the
calculated value (Table 1) for BBMV. These results dem-
onstrate that Cry1Ab binds specifically with high affinity to
PBW BT-R, 866. Other truncation fragments were also
tested, and it was determined that the minimum binding
fragment consists of amino acids 1269 to 1367.
Results: Expression of PBW BT-R, in COS-7 Cells.
PBW BIT-R, cDNA was subcloned into the mammalian
expression vector pcDNA3.1 INVITROGEN™)and trans-
fected into COS-7 cells. Protein encoded by the PBW BT-R,
cDNA was expressed as a membrane protein capable of
binding Cry1Ab toxin. Membranesisolated from transiently
transfected COS-7 cells were solubilized, electrophoresed,
and immunoblotted either with Cry1Ab toxin andits anti-
serum or with BT-R, antiserum directly. The expressed 220
kD receptor bound Cry1Ab toxin and cross-reacted with
BIT-R, antiserum. No interaction to vector transfected cells
was observed.
Expression of BT-R, receptor on the cell surface was
shown by fixing the cells in methanol or paraformaldehyde
and incubating first with anti-BT-R, serum, and then with
TRITC IgG secondary antibodies. Transfected cells por-
trayed bright surfaces due to the binding ofBT-R, antibodies
to the cell surface clearly showing that the PBW BT-R,
receptor is expressed on the cell surface.
The surface-expressed PBWreceptor binds toxin and kills
the cells. Transfected cells were incubated with CrylAb
toxin for 2 or 4 hr, washed, fixed and incubated first with
anti-Cry1Ab antiserum, and then with TRITC IgG second-
ary antibodies. As shown by immunofluorescence micros-
copy, BI-R, expressing COS-7 cells bound the toxin,
whereascells transfected with vector alone did not show any
surface binding of toxin. Incubation of cells expressing
PBW BT-R, with toxin for 2 or 4 hr showed significant
morphological changes which include loss of cell integrity,
loss of cell cytoplasm and complete disintegration of the
plasma membraneand cell death.
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SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 18
<210> SEQ ID NO 1
<211> LENGTH: 5527
<212> TYPE: DNA
<213> ORGANISM: Pectinophora gossypiella
<400> SEQUENCE: 1
aacatttaca tacagccagt gtagatgaca cattgattta aaaaaaatag tgcgagtgat 60
ttgaatctgt gatttcaaat atagaatcaa aaggactgca ttagtgttgt gggagttaaa 120
gtgtttgtga gaatagacca acgaccatgc aagatggcgg gtgacgcctg catactggtg 180
acggtgcttc tcaccttcge aacatcagtt ttcgggcaag aaacaacatc gtcgagatgt 240
tactacatga ctgacgctat tccgagggaa ccgaaaccgg atgatttgcc tgacttagaa 300
tggactggtg gatggaccga ctggcectttg atcccggctg agccaagaga cgacgtgtgc 360
ataaacggct ggtacccaca actcaccage acttctctcg gcaccatcat catccacatg 420
gaagaggaga tcgagggaga tgttgctatc gctaaactta actatgatgg ttctgqgaacc 480
ccagaaattg tccagcecgat ggttatagga tcttctaace tgctaagtce agagatccgg 540
aatgaaaacg gggcgtggta cctttatata accaatagge aagattatga aacaccaaca 600
atgcegtcggt atacattcga cgtccgagtg ccagacgaga ctcgtgcgge acgagtgagt 660
ctgtccatcg aaaacattga cgataacgac cctatcgtca gggtgctaga cgcttgccaa 720
gtgcecggaat tgggggagee tcgactaaca gactgcgttt accaagtgtc agacgaagat 780
gggaggctta gtatcgagee catgacattc cgcctcacat cagaccgtga agacgtacag 840
atattctatg tggagccage tcacattact ggtgattggt tcaacatgca aattactatc 900
ggtatcctat cagcegcttaa cttcgaaage aacccgctge acatctttca aatcactgct 960
ttggactcct ggcccaacaa ccatacggtg acggtgatgg tgcaagtcca gaatgtggaa 1020
caccgaccge cgcgatggat ggaaatcttc gcagtccage agtttgacga gatgacggag 1080
cagcaattce aggtgcegcege catcgacgga gacactggca tcgggaaage tatacactat 1140
accctcgaga cagatgagga agaagatttg ttcttcatcg aaacacttce gggcggccat 1200
gacggagcca tcttcagcac tgccatgatt gatgtggata ggctccggcg agatgtcttc 1260
agactgtcce tggtggcata caagtacgac aatgtgtcct tcgcecaccce gacacccgtc 1320
gtgatcatag tcaatgacat caacaacaag aaaccccaac cgctgcaaga tgagtacaca 1380
atctccataa tggaagaaac tccactgtcg ctgaattttg ctgaactttt tggtttctat 1440
gatgaagatt tgatctacge acaatccttg gtggaaatac aaggcgagaa ccctccagge 1500
gtagagcaag cgttttatat tgcgeccace gcaggcttce agaaccagac attcgccata 1560
gggactcaag atcaccgaat gctggattat gaggatgttc ctttccaaaa catcaagctc 1620
aaggtaatag caacggaccg tgacaatacc aattttactg gagtcgcgga agtcaacgtg 1680
aacctgatta attggaacga cgaggagccg atctttgagg aagaccagct cgttgtcaag 1740
ttcaaggaga ctgtacccaa ggactatcac gtcggcagac tgagggctca cgaccgggac 1800
ataggagaca gcgttgtgca ttccatcttg ggaaatgega atacattttt gagaatcgac 1860
23
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-continued
gaagaaactg gcgacatata cgtagctatt gatgacgcgt tcgattatca cagacagaat 1920
gaatttaaca tacaagttcg cgctcaggac accatgtcgg agccagagtc caggcataca 1980
geggctgcte agctggtcat agaactcgag gacgtcaaca acacacctcce tactctgagg 2040
etgectcgceg taagtccgtc tgtagaagag aatgtgccag agggctttga aatcaaccgg 2100
gagataaccg ccacggacce tgacaccaca gcatacctgc agtttgaaat agattgggac 2160
acatcctttg ccactaaaca ggggcgtgat accaatccaa tagagttcca cggatgcegtg 2220
gatatagaaa ccatcttccc aaacccagecc gacaccagag aggctgtggg gcgagtggta 2280
gcgaagggga tccgccataa cgtgaccatc cattttgaag agtttgaatt tctctacctc 2340
acagtgagag ttcgggactt gcacacagat gacggacgag attatgatga atctaccttc 2400
acggtaataa taatagatat gaacgacaac tggcectatct gggcegtctgg tttcctgaac 2460
cagaccttca gtattcggga gcgatcatct accggcgtcg tcatcgggtc cgtactcgct 2520
acagacattg atggcccact ttacaaccaa gtccggtaca ccattatccce ccaggaagat 2580
actcctgaag gtctagtcca gatacatttc gttacgggtc aaattacagt tgatgagaat 2640
ggtgcaatcg acgctgatat tccacctcgt tggcacctca actacacggt tatagccagc 2700
gacaaatgtt ctgaagaaaa tgaagagaac tgtcccccgg atccagtgtt ctgggatact 2760
etgcegcegaca atgtaattaa catcgtggac ataaacaaca aggtcccggc agcagacctc 2820
agtcgattca acgaaacggt gtacatttat gaaaatgcac ccgatttcac gaacgtggtc 2880
aagatatact ccatcgacga agacagagac gaaatatatc acacggtgcg gtaccagatc 2940
aattatgctg tgaaccaacg gctgcgagac ttcttcgcca tagacctgga ttcaggcecag 3000
gtgtacgtgg agaagaccaa caatgagctc ctggatcggg acagaggcga agaccaacac 3060
aggatattca ttaacctcat tgacaacttt tatagcgaag gagatggaaa tagaaatgta 3120
aacactacag aggtgctggt gatactatta gatgagaatg acaacgctce tgaattgecg 3180
actccagaag agctgagttg gagcatttcc gaggatttac aagagggtat aacactcgat 3240
ggcgaaagceg atgtgatata cgcaccggat atagacaaag aggacacgcc aaactctcac 3300
gttggctacg caatcctggc catgacagtc accaatagag acctggacac tgttccgaga 3360
cttctcaaca tgctgtcgcc taacaacgta accggattce tccagacage aatgectttg 3420
agaggatatt gggggactta cgatataagt gtactggcgt tcgaccacgg tattcctcag 3480
cagatatctc atgaggtgta tgaattggaa attcgacctt acaattacaa tcctcctcag 3540
ttegtttttc ctgaatccgg gacgattcta cgactggctt tggaacgege agtggtaaat 3600
aatgttttgt cacttgtaaa cggtgacccg ttagacagga tacaagcaat tgacgacgat 3660
ggtcttgatg ctggcgtggt gactttcgat attgttggag atgctgatge gtcaaactac 3720
ttcagagtaa ataatgatgg cgacagcttt ggaaccttgt tgctgacaca ggegcttcct 3780
gaggaaggca aggaatttga ggttaccatc cgggctacag acggcggaac agaacctcga 3840
tcatattcaa cagactccac tataacagtc ctcttcgttce cgactttggg tgatccgatc 3900
tttcaagata acacttactc agtagcattg tttgaaaaag aggttggctt gactgagagg 3960
ttcetegctce cacatgcaga ggaccctaag aacaaactct gcactgacga ctgtcacgat 4020
atttactaca ggatctttgg tggtgtggat tacgagcecat ttgacctgga cccggtgacg 4080
aacgtgatct tcctgaaatc agaactagac cgggagacca ctgctacgca tgtgqgtgcaa 4140
gtggcagcca gtaattcgcec cacaggaggc ggaataccac tecctgggtc tcttctcacc 4200
gtcactgtca ctgtacgaga agcggatcca cggcctgtgt tcgagcageg tctgtacacg 4260
25
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-continued
gctggcattt ccacttccga taacatcaac agggaactac tcaccgttcg tgcaactcat 4320
tccgaaaacg cacaattgac atataccatc gaagacggtt gtatggcggt ggactccact 4380
ctggaagecg tcaaggactc ggcgttccat ctgaacgcge agaccggcgt cctcatactg 4440
aggatacaac ctactgccag catgcagggc atgtttgagt tcaacgtcat cgctactgac 4500
ccagatgaga agacagatac ggcagaggtg aaagtctacc tcatttcatc ccaaaatagg 4560
gtgtccttca tattcctgaa cgatgtggag acggttgaga gtaacagaga ctttatcgca 4620
gaaacgttca gcegttggctt caacatgacc tgcaatatag atcaggtgcet gecgggcacc 4680
aacgacgccg gggtgattca ggaggccatg gcggaagtce atgctcactt catacaggat 4740
aacatccctg tgagcgcecga cagtattgaa gagcttcgca gtgacactca gcetgctgcgc 4800
tccegtccaag gtgtgttgaa ccaacggctg ttggtcctga acgacctggt gacgggggtc 4860
agecctgate tcggcactge cggcgtgcag atcaccatct atgtgctage cgggttgtca 4920
gccatccttg ccttcctgtg ccttattctg ctcatcacat tcatcgtgag gacccgagct 4980
etgaaccgce gtttggaage actgtcgatg acgaaatacg gctcggtgga ttcggggctg 5040
aaccgagtgg ggatagcggce cccaggaacc aacaaacacg ccatcgaagg ctccaaccce 5100
atctggaacg agcagatcaa ggccccggac ttcgatgcca tcagtgacac atctgacgac 5160
tctgatctaa tcggcatcga ggatagectg cagggagact tagaagagaa aagggcagac 5220
aaagcagtag atgccttggt gaaaaagctg aagaagaacg atgqgagccat gggggaatac 5280
gaattcaagg cctctcgage ctctagaact atcgtgagtc gtattacgta tatccagaca 5340
tgatgagata cattgatgag tttggacaaa ccgcaactag aatgcagtga aaaaaatgct 5400
ttatttgttg aaatttgtga tgctattgct ttatttggaa ccattataag ctgcaataaa 5460
caagttaaca tcatcaattg cattcatttt atgtttcagg ttcaggggga ggtgtgggag 5520
gctatcc 5527
<210> SEQ ID NO 2
<211> LENGTH: 1729
<212> TYPE: PRT
<213> ORGANISM: Pectinophora gossypiella
<400> SEQUENCE: 2
Met Ala Gly
1
Thr
Thr
Glu
Arg
65
ser
val
val
Arg
ser
Asp
Trp
50
Asp
Leu
Ala
Gln
Asn
130
val
Ala
35
Thr
Asp
Gly
Ile
Pro
115
Glu
Asp Ala Cys Ile Leu
Phe Gly Gln Glu Thr
20
Ile Pro Arg Glu Pro
40
Gly Gly Trp Thr Asp
55
Val Cys Ile Asn Gly
70
Thr Ile Ile Ile His
85
Ala Lys Leu Asn Tyr
100
Met Val Ile Gly Ser
120
Asn Gly Ala Trp Tyr
135
Val Thr Val
10
Thr Ser Ser
25
Lys Pro Asp
Trp Pro Leu
Trp Tyr Pro
75
Met Glu Glu
90
Asp Gly Ser
105
Ser Asn Leu
Leu Tyr Ile
Leu Leu Thr
Arg Cys Tyr
30
Asp Leu Pro
45
Ile Pro Ala
Gln Leu Thr
Glu Ile Glu
Gly Thr Pro
110
Leu Ser Pro
125
Thr Asn Arg
140
Phe Ala
15
Tyr Met
Asp Leu
Glu Pro
Ser Thr
80
Gly Asp
95
Glu Ile
Glu Ile
Gln Asp
27
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Tyr
145
Asp
Asp
Leu
Asp
Arg
225
Asp
Phe
Trp
Glu
Asp
305
Thr
Glu
Ile
Phe
Thr
385
Pro
Pro
Leu
Gly
Gln
465
Asp
Asp
Asn
Lys
Ala
545
Glu
Glu
Asn
Gly
Gly
210
Glu
Trp
Glu
Pro
His
290
Glu
Gly
Asp
Phe
Arg
370
Pro
Gln
Leu
Ile
val
450
Thr
val
Asn
Trp
Phe
530
His
Thr
Thr
Asp
Glu
195
Arg
Asp
Phe
ser
Asn
275
Arg
Met
Ile
Leu
ser
355
Leu
Thr
Pro
ser
Tyr
435
Glu
Phe
Pro
Thr
Asn
515
Lys
Asp
Pro
Arg
Pro
180
Pro
Leu
val
Asn
Asn
260
Asn
Pro
Thr
Gly
Phe
340
Thr
ser
Pro
Leu
Leu
420
Ala
Gln
Ala
Phe
Asn
500
Asp
Glu
Arg
Thr
Ala
165
Ile
Arg
ser
Gln
Met
245
Pro
His
Pro
Glu
Lys
325
Phe
Ala
Leu
val
Gln
405
Asn
Gln
Ala
Ile
Gln
485
Phe
Glu
Thr
Asp
Met
150
Ala
val
Leu
Ile
Ile
230
Gln
Leu
Thr
Arg
Gln
310
Ala
Ile
Met
val
val
390
Asp
Phe
ser
Phe
Gly
470
Asn
Thr
Glu
val
Ile
550
Arg
Arg
Arg
Thr
Glu
215
Phe
Ile
His
val
Trp
295
Gln
Ile
Glu
Ile
Ala
375
Ile
Glu
Ala
Leu
Tyr
455
Thr
Ile
Gly
Pro
Pro
535
Gly
Arg
val
val
Asp
200
Pro
Tyr
Thr
Ile
Thr
280
Met
Phe
His
Thr
Asp
360
Tyr
Ile
Tyr
Glu
val
440
Ile
Gln
Lys
val
Ile
520
Lys
Asp
Tyr
ser
Leu
185
Cys
Met
val
Ile
Phe
265
val
Glu
Gln
Tyr
Leu
345
val
Lys
val
Thr
Leu
425
Glu
Ala
Asp
Leu
Ala
505
Phe
Asp
ser
Thr
Leu
170
Asp
val
Thr
Glu
Gly
250
Gln
Met
Ile
val
Thr
330
Pro
Asp
Tyr
Asn
Ile
410
Phe
Ile
Pro
His
Lys
490
Glu
Glu
Tyr
val
Phe
155
ser
Ala
Tyr
Phe
Pro
235
Ile
Ile
val
Phe
Arg
315
Leu
Gly
Arg
Asp
Asp
395
ser
Gly
Gln
Thr
Arg
475
val
val
Glu
His
val
555
Asp Val Arg Val
Ile Glu Asn Ile
175
Cys Gln Val Pro
190
Gln Val Ser Asp
205
Arg Leu Thr Ser
220
Ala His Ile Thr
Leu Ser Ala Leu
255
Thr Ala Leu Asp
270
Gln Val Gln Asn
285
Ala Val Gln Gln
300
Ala Ile Asp Gly
Glu Thr Asp Glu
335
Gly His Asp Gly
350
Leu Arg Arg Asp
365
Asn Val Ser Phe
380
Ile Asn Asn Lys
Ile Met Glu Glu
415
Phe Tyr Asp Glu
430
Gly Glu Asn Pro
445
Ala Gly Phe Gln
460
Met Leu Asp Tyr
Ile Ala Thr Asp
495
Asn Val Asn Leu
510
Asp Gln Leu Val
525
Val Gly Arg Leu
540
His Ser Ile Leu
Pro
160
Asp
Glu
Glu
Asp
Gly
240
Asn
ser
val
Phe
Asp
320
Glu
Ala
val
Ala
Lys
400
Thr
Asp
Pro
Asn
Glu
480
Arg
Ile
val
Arg
Gly
560
29
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Asn
val
Ile
Thr
Pro
625
val
Asp
Ala
val
val
705
Phe
Ile
Asn
Gly
785
Arg
Ile
Asp
ser
val
865
Asn
Tyr
ser
Ile
Leu
945
Asp
Asp
Ala
Ala
Gln
Ala
610
Pro
Pro
Thr
Thr
Asp
690
Gly
Glu
Thr
Ile
Gln
770
ser
Tyr
His
Ala
Asp
850
Phe
Asn
Ile
Ile
Asn
930
Asp
Arg
Asn
Asn
Ile
val
595
Ala
Thr
Glu
Thr
Lys
675
Ile
Arg
Glu
Asp
Asp
755
Thr
val
Thr
Phe
Asp
835
Lys
Trp
Lys
Tyr
Asp
915
Tyr
ser
Asp
Phe
Thr
Asp
580
Arg
Ala
Leu
Gly
Ala
660
Gln
Glu
val
Phe
Asp
740
Met
Phe
Leu
Ile
val
820
Ile
Cys
Asp
val
Glu
900
Glu
Ala
Gly
Arg
Tyr
Phe
565
Asp
Ala
Gln
Arg
Phe
645
Tyr
Gly
Thr
val
Glu
725
Gly
Asn
ser
Ala
Ile
805
Thr
Pro
ser
Thr
Pro
885
Asn
Asp
val
Gln
Gly
965
ser
Leu
Ala
Gln
Leu
Leu
630
Glu
Leu
Arg
Ile
Ala
710
Phe
Arg
Asp
Ile
Thr
790
Pro
Gly
Pro
Glu
Leu
870
Ala
Ala
Arg
Asn
val
950
Glu
Glu
Arg
Phe
Asp
val
615
Pro
Ile
Gln
Asp
Phe
695
Lys
Leu
Asp
Asn
Arg
775
Asp
Gln
Gln
Arg
Glu
855
Arg
Ala
Pro
Asp
Gln
935
Tyr
Asp
Gly
Ile
Asp
Thr
600
Ile
Arg
Asn
Phe
Thr
680
Pro
Gly
Tyr
Tyr
Trp
760
Glu
Ile
Glu
Ile
Trp
840
Asn
Asp
Asp
Asp
Glu
920
Arg
val
Gln
Asp
Asp
Tyr
585
Met
Glu
val
Arg
Glu
665
Asn
Asn
Ile
Leu
Asp
745
Pro
Arg
Asp
Asp
Thr
825
His
Glu
Asn
Leu
Phe
905
Ile
Leu
Glu
His
Gly
Glu
570
His
ser
Leu
ser
Glu
650
Ile
Pro
Pro
Arg
Thr
730
Glu
Ile
ser
Gly
Thr
810
val
Leu
Glu
val
ser
890
Thr
Tyr
Arg
Asn
Arg
970
Asn
Glu
Arg
Glu
Glu
Pro
635
Ile
Asp
Ile
Ala
His
715
val
ser
Trp
ser
Pro
795
Pro
Asp
Asn
Asn
Ile
875
Arg
Asn
His
Asp
Thr
955
Ile
Arg
Thr Gly Asp Ile
Gln
Pro
Asp
620
ser
Thr
Trp
Glu
Asp
700
Asn
Arg
Thr
Ala
Thr
780
Leu
Glu
Glu
Tyr
Cys
860
Asn
Phe
val
Thr
Phe
940
Asn
Phe
Asn
Asn
Glu
605
val
val
Ala
Asp
Phe
685
Thr
val
val
Phe
ser
765
Gly
Tyr
Gly
Asn
Thr
845
Pro
Ile
Asn
val
val
925
Phe
Asn
Ile
val
Glu
590
ser
Asn
Glu
Thr
Thr
670
His
Arg
Thr
Arg
Thr
750
Gly
val
Asn
Leu
Gly
830
val
Pro
val
Glu
Lys
910
Arg
Ala
Glu
Asn
Asn
575
Phe
Arg
Asn
Glu
Asp
655
ser
Gly
Glu
Ile
Asp
735
val
Phe
val
Gln
val
815
Ala
Ile
Asp
Asp
Thr
895
Ile
Tyr
Ile
Leu
Leu
975
Thr
Tyr
Asn
His
Thr
Asn
640
Pro
Phe
Cys
Ala
His
720
Leu
Ile
Leu
Ile
val
800
Gln
Ile
Ala
Pro
Ile
880
val
Tyr
Gln
Asp
Leu
960
Ile
Thr
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980 985 990
Glu Val Leu Val Ile Leu Leu Asp Glu Asn Asp Asn Ala Pro Glu Leu
995 1000 1005
Pro Thr Pro Glu Glu Leu Ser Trp Ser Ile Ser Glu Asp Leu Gln Glu
1010 1015 1020
Gly Ile Thr Leu Asp Gly Glu Ser Asp Val Ile Tyr Ala Pro Asp Ile
1025 1030 1035 1040
Asp Lys Glu Asp Thr Pro Asn Ser His Val Gly Tyr Ala Ile Leu Ala
1045 1050 1055
Met Thr Val Thr Asn Arg Asp Leu Asp Thr Val Pro Arg Leu Leu Asn
1060 1065 1070
Met Leu Ser Pro Asn Asn Val Thr Gly Phe Leu Gln Thr Ala Met Pro
1075 1080 1085
Leu Arg Gly Tyr Trp Gly Thr Tyr Asp Ile Ser Val Leu Ala Phe Asp
1090 1095 1100
His Gly Ile Pro Gln Gln Ile Ser His Glu Val Tyr Glu Leu Glu Ile
1105 1110 1115 1120
Arg Pro Tyr Asn Tyr Asn Pro Pro Gln Phe Val Phe Pro Glu Ser Gly
1125 1130 1135
Thr Ile Leu Arg Leu Ala Leu Glu Arg Ala Val Val Asn Asn Val Leu
1140 1145 1150
Ser Leu Val Asn Gly Asp Pro Leu Asp Arg Ile Gln Ala Ile Asp Asp
1155 1160 1165
Asp Gly Leu Asp Ala Gly Val Val Thr Phe Asp Ile Val Gly Asp Ala
1170 1175 1180
Asp Ala Ser Asn Tyr Phe Arg Val Asn Asn Asp Gly Asp Ser Phe Gly
1185 1190 1195 1200
Thr Leu Leu Leu Thr Gln Ala Leu Pro Glu Glu Gly Lys Glu Phe Glu
1205 1210 1215
Val Thr Ile Arg Ala Thr Asp Gly Gly Thr Glu Pro Arg Ser Tyr Ser
1220 1225 1230
Thr Asp Ser Thr Ile Thr Val Leu Phe Val Pro Thr Leu Gly Asp Pro
1235 1240 1245
Ile Phe Gln Asp Asn Thr Tyr Ser Val Ala Phe Phe Glu Lys Glu Val
1250 1255 1260
Gly Leu Thr Glu Arg Phe Ser Leu Pro His Ala Glu Asp Pro Lys Asn
1265 1270 1275 1280
Lys Leu Cys Thr Asp Asp Cys His Asp Ile Tyr Tyr Arg Ile Phe Gly
1285 1290 1295
Gly Val Asp Tyr Glu Pro Phe Asp Leu Asp Pro Val Thr Asn Val Ile
1300 1305 1310
Phe Leu Lys Ser Glu Leu Asp Arg Glu Thr Thr Ala Thr His Val Val
1315 1320 1325
Gln Val Ala Ala Ser Asn Ser Pro Thr Gly Gly Gly Ile Pro Leu Pro
1330 1335 1340
Gly Ser Leu Leu Thr Val Thr Val Thr Val Arg Glu Ala Asp Pro Arg
1345 1350 1355 1360
Pro Val Phe Glu Gln Arg Leu Tyr Thr Ala Gly Ile Ser Thr Ser Asp
1365 1370 1375
Asn Ile Asn Arg Glu Leu Leu Thr Val Arg Ala Thr His Ser Glu Asn
1380 1385 1390
Ala Gln Leu Thr Tyr Thr Ile Glu Asp Gly Ser Met Ala Val Asp Ser
1395 1400 1405
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Thr Leu Glu Ala Val Lys Asp Ser Ala Phe His Leu Asn Ala Gln Thr
1410 1415 1420
Gly Val Leu Ile Leu Arg Ile Gln Pro Thr Ala Ser Met Gln Gly Met
1425 1430 1435 1440
Phe Glu Phe Asn Val Ile Ala Thr Asp Pro Asp Glu Lys Thr Asp Thr
1445 1450 1455
Ala Glu Val Lys Val Tyr Leu Ile Ser Ser Gln Asn Arg Val Ser Phe
1460 1465 1470
Ile Phe Leu Asn Asp Val Glu Thr Val Glu Ser Asn Arg Asp Phe Ile
1475 1480 1485
Ala Glu Thr Phe Ser Val Gly Phe Asn Met Thr Cys Asn Ile Asp Gln
1490 1495 1500
Val Leu Pro Gly Thr Asn Asp Ala Gly Val Ile Gln Glu Ala Met Ala
1505 1510 1515 1520
Glu Val His Ala His Phe Ile Gln Asp Asn Ile Pro Val Ser Ala Asp
1525 1530 1535
Ser Ile Glu Glu Leu Arg Ser Asp Thr Gln Leu Leu Arg Ser Val Gln
1540 1545 1550
Gly Val Leu Asn Gln Arg Leu Leu Val Leu Asn Asp Leu Val Thr Gly
1555 1560 1565
Val Ser Pro Asp Leu Gly Thr Ala Gly Val Gln Ile Thr Ile Tyr Val
1570 1575 1580
Leu Ala Gly Leu Ser Ala Ile Leu Ala Phe Leu Cys Leu Ile Leu Leu
1585 1590 1595 1600
Ile Thr Phe Ile Val Arg Thr Arg Ala Leu Asn Arg Arg Leu Glu Ala
1605 1610 1615
Leu Ser Met Thr Lys Tyr Gly Ser Val Asp Ser Gly Leu Asn Arg Val
1620 1625 1630
Gly Ile Ala Ala Pro Gly Thr Asn Lys His Ala Ile Glu Gly Ser Asn
1635 1640 1645
Pro Ile Trp Asn Glu Gln Ile Lys Ala Pro Asp Phe Asp Ala Ile Ser
1650 1655 1660
Asp Thr Ser Asp Asp Ser Asp Leu Ile Gly Ile Glu Asp Ser Leu Gln
1665 1670 1675 1680
Gly Asp Leu Glu Glu Lys Arg Ala Asp Lys Ala Val Asp Ala Leu Val
1685 1690 1695
Lys Lys Leu Lys Lys Asn Asp Gly Ala Met Gly Glu Tyr Glu Phe Lys
1700 1705 1710
Ala Ser Arg Ala Ser Arg Thr Ile Val Ser Arg Ile Thr Tyr Ile Gln
1715 1720 1725
Thr
<210> SEQ ID NO 3
<211> LENGTH: 23
<212> TYPE: DNA
<213> ORGANISM: Artificial sequence
<220> FEATURE:
<223> OTHER INFORMATION: BTR 1209U primer
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (3)
<223> OTHER INFORMATION: n = A, G, C, or T
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (9)
<223> OTHER INFORMATION: n = A, G, C, or T
<220> FEATURE:
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<221> NAME/KEY: misc_feature
<222> LOCATION: (12)
<223> OTHER INFORMATION: n =A, G, C, or T
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (15)
<223> OTHER INFORMATION: n =A, G, C, or T
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (21)
<223> OTHER INFORMATION: n =A, G, C, or T
<400> SEQUENCE: 3
canathcgng cncangaygg ngg 23
<210> SEQ ID NO 4
<211> LENGTH: 23
<212> TYPE: DNA
<213> ORGANISM: Artificial sequence
<220> FEATURE:
<223> OTHER INFORMATION: BTR 1355U primer
<400> SEQUENCE: 4
ttgtacacsg cwggsatwtc cac 23
<210> SEQ ID NO 5
<211> LENGTH: 24
<212> TYPE: DNA
<213> ORGANISM: Artificial sequence
<220> FEATURE:
<223> OTHER INFORMATION: BTR 1486d primer
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (1)
<223> OTHER INFORMATION: n =A, G, C, or T
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (19)
<223> OTHER INFORMATION: n =A, G, C, or T
<400> SEQUENCE: 5
nacytgrtcr atrttrcang tcat 24
<210> SEQ ID NO 6
<211> LENGTH: 24
<212> TYPE: DNA
<213> ORGANISM: Artificial sequence
<220> FEATURE:
<223> OTHER INFORMATION: BTR 1657D primer
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (1)
<223> OTHER INFORMATION: n =A, G, C, or T
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (7)
<223> OTHER INFORMATION: n =A, G, C, or T
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (13)
<223> OTHER INFORMATION: n =A, G, C, or T
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (22)
<223> OTHER INFORMATION: n =A, G, C, or T
<400> SEQUENCE: 6
necdatnagr tcengartecrt tnga 24
<210> SEQ ID NO 7
<211> LENGTH: 24
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<212>
<213>
<220>
<223>
<400>
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: PBW-BTR GSP-1 primer
SEQUENCE: 7
taggttgtat cctcagtatg agga 24
<210>
<211>
<212>
<213>
<220>
<223>
<400>
SEQ ID NO 8
LENGTH: 23
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: PBW-BTR GSP-2 primer
SEQUENCE: 8
ccagagtgga gtccaccgce ata 23
<210>
<211>
<212>
<213>
<220>
<223>
<400>
SEQ ID NO 9
LENGTH: 23
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: PBW-BTR GSP-3 primer
SEQUENCE: 9
ctgagtaagt gttatcttga aag 23
<210>
<211>
<212>
<213>
<220>
<223>
<220>
<221>
<222>
<223>
<220>
<221>
<222>
<223>
<220>
<221>
<222>
<223>
<220>
<221>
<222>
<223>
<220>
<221>
<222>
<223>
<400>
SEQ ID NO 10
LENGTH: 23
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: BTR 1209U primer
FEATURE:
NAME/KEY: misc_featureLOCATION: (3)
OTHER INFORMATION: n = A, G, C, or T
FEATURE:
NAME/KEY: misc_featureLOCATION: (9)
OTHER INFORMATION: n = A, G, C, or T
FEATURE:
NAME/KEY: misc_featureLOCATION: (12)
OTHER INFORMATION: n = A, G, C, or T
FEATURE:
NAME/KEY: misc_featureLOCATION: (15)
OTHER INFORMATION: n = A, G, C, or T
FEATURE:
NAME/KEY: misc_featureLOCATION: (21)
OTHER INFORMATION: n = A, G, C, or T
SEQUENCE: 10
canathcgng cncangaygg ngg 23
<210>
<211>
<212>
<213>
<220>
<223>
<400>
SEQ ID NO 11
LENGTH: 29
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: PBW-BTR GSP-4 primer
SEQUENCE: 11
gatageggce ccaggaacca acaaacagg 29
<210> SEQ ID NO 12
39
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<211>
<212>
<213>
<220>
<223>
<400>
LENGTH: 24
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: PBW-BTR P2U primer
SEQUENCE: 12
agtgcgagtg ctttgaatct gtga
<210>
<211>
<212>
<213>
<220>
<223>
<400>
SEQ ID NO 13
LENGTH: 25
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: PBW-BTR P5U primer
SEQUENCE: 13
gtctcttcte accgtcactg tcact
<210>
<211>
<212>
<213>
<220>
<223>
<400>
SEQ ID NO 14
LENGTH: 23
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: PBW-BTR P6D primer
SEQUENCE: 14
gcatgctgge agtaggttgt atc
<210>
<211>
<212>
<213>
<220>
<223>
<400>
SEQ ID NO 15
LENGTH: 20
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: (AUAP) primer
SEQUENCE: 15
ggccacgcegt cgactagtac
<210>
<211>
<212>
<213>
<220>
<223>
<400>
SEQ ID NO 16
LENGTH: 37
TYPE: DNA
ORGANISM: Artificial sequence
FEATURE:
OTHER INFORMATION: (AP) primer
SEQUENCE: 16
ggccacgegt cgactagtac tttttttttt ttttttt
<210>
<211>
<212>
<213>
<400>
SEQ ID NO 17
LENGTH: 1715
TYPE: PRT
ORGANISM: B. mori
SEQUENCE: 17
Met Gly Val Asp Val Arg Ile Leu Ala Thr
1
Glu Thr Val Leu Ala Gln Glu Arg Cys Gly
20 25
Arg Pro Pro Arg Pro Asp Leu Pro Glu Leu
Trp Ser Gln Arg Pro Leu Ile Pro Ala Ala
50 55
Met Asp Gly Tyr His Ala Met Thr Pro Thr
Leu
Phe
Asp
Asp
Tyr
Leu
Met
Phe
Arg
60
Gly
Leu
val
Glu
Glu
Thr
Ile
Ala
30
Gly
Asp
Gln
Tyr
15
Ile
Gln
val
Ile
Ala
Pro
Thr
Cys
Ile
24
25
23
20
37
41
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65
Tyr
Tyr
ser
Gly
Gly
145
val
Ile
Arg
ser
Lys
225
Met
Pro
Pro
Ala
305
Lys
Asp
Ile
val
385
Phe
Asn
Ala
Lys
Ile
465
Phe
Met
Arg
Phe
Glu
130
Met
Ala
Ile
Leu
Thr
210
Ile
Thr
Leu
Thr
Arg
290
Gln
Pro
Ile
Pro
Ile
370
val
Lys
Phe
Gln
Ala
450
Met
Gln
Glu
Gly
Asn
115
Trp
Gln
Gly
Gln
Thr
195
Gln
Phe
Met
His
val
275
Trp
ser
Ile
Arg
Ile
355
Ala
Ile
Glu
Asp
Tyr
435
Phe
Gly
Arg
Glu
Pro
100
Leu
His
Gln
val
Ala
180
Glu
Phe
Tyr
Thr
Ile
260
Thr
val
Phe
His
Thr
340
Asp
Tyr
Ile
Tyr
Gln
420
Thr
Tyr
Thr
Ile
Glu
85
Asn
Leu
Leu
Tyr
ser
165
Leu
Cys
Met
Ile
val
245
Phe
Leu
Glu
Pro
Tyr
325
Ile
Arg
Lys
val
Arg
405
Glu
val
Ile
Ala
Arg
485
70
Ile
val
val
Ile
val
150
Leu
Glu
val
Gln
Gln
230
Gly
ser
Met
Ile
val
310
Arg
Glu
Asp
Tyr
Asn
390
Leu
Phe
Arg
Ala
Asn
470
Leu
Glu
Pro
Pro
Ile
135
Phe
Leu
Pro
Tyr
Phe
215
Gly
Ile
val
val
Phe
295
Arg
Leu
Gly
Thr
Asp
375
Asp
Asn
Gly
Leu
Pro
455
His
Arg
Gly
Tyr
val
120
Thr
Asn
Ile
Cys
val
200
Arg
Ala
Asn
Thr
Gln
280
Ala
Ala
Glu
Gly
Leu
360
Asn
Ile
Ile
Phe
Glu
440
Glu
Lys
val
Glu
Ile
105
Ile
Gln
Ile
val
Gln
185
val
Ile
Asn
Glu
Ala
265
val
val
Ile
Thr
Arg
345
Gln
Glu
Asn
Met
His
425
ser
val
Met
Ile
val
90
Glu
Arg
Arg
Arg
Asn
170
val
Thr
Asp
Ile
Pro
250
Leu
Glu
Gln
Asp
Ala
330
ser
Arg
ser
Asp
Glu
410
Asp
Asp
Gly
Leu
Ala
490
75
Pro
Pro
Arg
Gln
Ile
155
Ile
Asp
Asp
ser
Pro
235
Leu
Asp
Asn
Gln
Gly
315
Glu
Gly
Glu
ser
Gln
395
Glu
Arg
Tyr
Tyr
Asp
475
Thr
Ile
Ala
Ile
Asp
140
Asp
Asp
Glu
Ala
Asp
220
Gly
Asn
ser
val
Phe
300
Asp
Glu
Ala
val
Ala
380
Arg
Thr
Asp
Pro
Gln
460
Tyr
Asp
Ala
Phe
Pro
125
Tyr
Gly
Asp
Leu
Asp
205
Arg
Glu
Phe
Leu
Glu
285
Asp
Thr
Asp
Ile
Phe
365
Thr
Pro
Ala
Leu
Ala
445
Arg
Glu
Met
Lys
Leu
110
Asp
Glu
Glu
Asn
Gly
190
Gly
Gly
Trp
Glu
Pro
270
His
Glu
Gly
Thr
Leu
350
Gln
Ala
Glu
Leu
Gly
430
Asp
Gln
val
Asp
Leu
95
ser
ser
Thr
Thr
Ala
175
Glu
Arg
Asp
Ile
Thr
255
Asn
Arg
Lys
Ile
Phe
335
Tyr
Leu
Ala
Pro
Thr
415
Gln
Ala
Thr
Pro
Asn
495
80
Asn
Gly
Asn
Pro
Leu
160
Pro
Ala
Ile
Asp
Arg
240
Asn
Thr
Pro
Thr
Asn
320
Phe
val
ser
Asn
Leu
400
Leu
Asn
Ala
Phe
Glu
480
Glu
43
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Glu
Asp
Glu
Arg
545
Asn
Asp
Arg
Leu
Leu
625
Ile
Leu
Arg
Ile
val
705
Met
Asp
Asp
val
Thr
785
Ala
Gly
Arg
Ala
Pro
865
Gln
Ala
His
Glu
Thr
530
Asp
Tyr
Asp
Ala
Leu
610
Pro
Ile
Arg
Glu
Tyr
690
Lys
Leu
Asp
Asn
Arg
770
Asp
Asn
Gln
Arg
Glu
850
Gly
Pro
val
val
Glu
515
Glu
Ile
Leu
Phe
Asp
595
Ile
Arg
Thr
Phe
Ala
675
Pro
Lys
Tyr
Tyr
Pro
755
Glu
Ile
Glu
Ile
Tyr
835
Asp
Gln
Glu
ser
Gly
500
Pro
Gly
Asp
ser
Phe
580
Asp
His
Gly
ser
Glu
660
Asn
Ala
Ile
Leu
Asp
740
Pro
Met
Asp
Gly
Thr
820
Asn
Pro
val
Thr
Gly
900
val
Ile
Lys
Asp
Ile
565
Asp
Thr
Glu
ser
Glu
645
Ile
Pro
Ile
Arg
Thr
725
Glu
Ile
ser
Gly
Thr
805
val
Leu
Asp
val
Asp
885
Asp
Ala
Phe
Gly
Arg
550
Asp
Tyr
Leu
Glu
Pro
630
Ile
Asp
Ile
Asn
Glu
710
val
ser
Trp
Asp
Pro
790
Pro
Lys
Tyr
Asp
Ile
870
Gln
Glu
Tyr
Glu
Phe
535
val
Lys
His
Gly
Asp
615
Asn
Arg
Trp
Glu
Asn
695
Asn
Arg
Thr
val
Ala
775
Leu
Glu
Thr
Tyr
Cys
855
Gln
Phe
val
val
His
520
Phe
Glu
Asp
Arg
Glu
600
Ile
val
Ala
Thr
Phe
680
Arg
val
val
Phe
Pro
760
Gly
Tyr
Asn
ser
Thr
840
Pro
Ile
Lys
val
Tyr
505
ser
val
His
Thr
Gln
585
Pro
Asn
Glu
Thr
Thr
665
His
Gly
Thr
Arg
Thr
745
Gly
val
Asn
Leu
Gly
825
val
Asp
Ile
Ala
Lys
905
Ile
val
Ala
Thr
Gly
570
ser
Phe
Asn
Glu
Asp
650
ser
Asn
ser
Ile
Asp
730
Ile
Thr
val
Gln
Leu
810
Ala
val
Asp
Asp
val
890
val
Asn
Gln
Asn
Leu
555
Asp
Glu
His
Thr
Asn
635
Pro
Tyr
Cys
Ala
Asp
715
Leu
Thr
Leu
Ile
val
795
Met
Ile
Ala
Pro
Thr
875
val
Ile
Leu
Asn
val
540
Met
Ile
Leu
Thr
Pro
620
val
Asp
Ala
val
Ile
700
Tyr
Asn
Ile
Glu
Gly
780
Arg
Glx
Asp
Thr
Thr
860
Asn
Tyr
Gly
Ile
val
525
Arg
Gly
His
Phe
Ala
605
Pro
Pro
Thr
Thr
Glu
685
Gly
Glu
Thr
Ile
Gln
765
Thr
Tyr
Asp
Ala
Asp
845
Tyr
Asn
Ile
ser
Asn
510
ser
Ala
Asn
val
val
590
Thr
Thr
Glu
Thr
Lys
670
Ile
Arg
Glu
val
Asp
750
ser
Leu
Thr
Phe
Asp
830
Arg
Trp
Lys
Tyr
Asp
910
Trp
Phe
His
Ala
Thr
575
Gln
ser
Leu
Gly
Ala
655
Gln
Glu
Leu
Phe
Ile
735
Met
Leu
Thr
Met
Tyr
815
val
Cys
Glu
Ile
Glu
895
Leu
Asn
Lys
Asp
Asn
560
Gln
val
Gln
Arg
Tyr
640
Glu
Gly
Thr
val
Glu
720
Gly
Asn
Arg
Ala
Lys
800
Thr
Pro
Tyr
Thr
Pro
880
Asp
Asp
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Arg Asp Asp Ile Tyr His Thr Ile Arg Tyr Gln Ile Asn Tyr Ala Val
915 920 925
Asn Pro Arg Leu Arg Asp Phe Phe Ala Val Asp Pro Asp Thr Gly Arg
930 935 940
Val Tyr Val Tyr Tyr Thr Thr Asp Glu Val Leu Asp Arg Asp Gly Asp
945 950 955 960
Glu Pro Gln His Arg Ile Phe Phe Asn Leu Ile Asp Asn Phe Phe Gln
965 970 975
Gln Gly Asp Gly Asn Arg Asn Gln Asn Asp Ala Glu Val Leu Val Val
980 985 990
Leu Leu Asp Val Asn Asp Asn Ala Pro Glu Leu Pro Glu Pro Asp Glu
995 1000 1005
Leu Ser Trp Ser Val Ser Glu Ser Leu Thr Lys Gly Thr Arg Leu Gln
1010 1015 1020
Pro His Ile Tyr Ala Pro Asp Arg Asp Glu Pro Asp Thr Asp Asn Ser
1025 1030 1035 1040
Arg Val Gly Tyr Ala Ile Ile Ser Leu Thr Ile Ala Asn Arg Glu Ile
1045 1050 1055
Glu Val Pro Glu Leu Phe Thr Met Ile Gln Ile Gln Asn Val Thr Gly
1060 1065 1070
Glu Leu Glu Thr Ala Met Asp Leu Arg Gly Tyr Trp Gly Thr Tyr Ala
1075 1080 1085
Ile His Ile Lys Ala Tyr Asp His Gly Ile Pro Gln Gln Met Ser Asn
1090 1095 1100
Glu Thr Tyr Glu Leu Val Ile Arg Pro Tyr Asn Phe His Ala Pro Val
1105 1110 1115 1120
Phe Val Phe Pro Lys His Gly Ala Thr Leu Arg Leu Ala Arg Glu Arg
1125 1130 1135
Ala Val Val Asn Gly Leu Leu Ala Thr Val Asp Gly Glu Phe Leu Asn
1140 1145 1150
Arg Ile Val Ala Thr Asp Glu Asp Gly Leu His Ala Gly Gln Val Ala
1155 1160 1165
Phe Glu Val Val Gly Asp Thr Glu Ala Val Asp Tyr Phe His Ile Val
1170 1175 1180
Asn Asp Gly Glu Asn Ser Gly Thr Leu Met Leu Lys Gln Leu Phe Pro
1185 1190 1195 1200
Glu Asp Ile Arg Glu Phe Glu Val Thr Ile Arg Ala Thr Asp Gly Gly
1205 1210 1215
Thr Glu Pro Arg Pro Leu Ser Thr Asp Cys Thr Phe Ser Val Val Phe
1220 1225 1230
Val Pro Ile Gln Gly Glu Pro Ile Phe Pro Thr Ser Thr His Thr Val
1235 1240 1245
Ala Phe Ile Glu Lys Glu Ala Gly Leu Leu Glu Arg His Glu Leu Pro
1250 1255 1260
Arg Ala Glu Asp Arg Lys Asn His Leu Cys Ser Asp Asp Cys His Asn
1265 1270 1275 1280
Ile Tyr Tyr Arg Ile Ile Asp Gly Asn Asn Asp Gly His Phe Gly Leu
1285 1290 1295
Asp Glu Thr Thr Asn Val Leu Phe Leu Val Lys Glu Leu Asp Arg Ser
1300 1305 1310
Val Ser Glu Thr Tyr Thr Leu Thr Ile Ala Ala Ser Asn Ser Pro Thr
1315 1320 1325
Gly Gly Ile Ala Leu Thr Ser Thr Ile Thr Ile Thr Val Asn Val Arg
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1330 1335 1340
Glu Ala Asp Pro Gln Pro Tyr Phe Val Arg Asp Leu Tyr Thr Ala Gly
1345 1350 1355 1360
Ile Ser Thr Ser Asp Ser Ile Asn Arg Glu Leu Leu Ile Leu Gln Ala
1365 1370 1375
Thr His Ser Glu Asn Ala Pro Ile Ile Tyr Thr Ile Asp Trp Ser Thr
1380 1385 1390
Met Val Thr Asp Pro Thr Leu Ala Ser Val Arg Glu Thr Ala Phe Ile
1395 1400 1405
Leu Asn Pro His Thr Gly Val Leu Thr Leu Asn Ile Gln Pro Thr Ala
1410 1415 1420
Ser Met His Gly Met Phe Glu Phe Gln Val Val Ala Thr Asp Pro Ala
1425 1430 1435 1440
Gly Tyr Ser Asp Arg Ala Asn Val Lys Ile Tyr Leu Ile Ser Thr Arg
1445 1450 1455
Asn Arg Val Phe Phe Leu Phe Val Asn Thr Leu Glu Gln Val Glu Gln
1460 1465 1470
Asn Thr Asp Phe Ile Ala Gln Thr Phe Ser Ala Gly Phe Glu Met Thr
1475 1480 1485
Cys Asn Ile Asp Gln Val Val Pro Ala Thr Asp Ala Ser Gly Val Ile
1490 1495 1500
Met Asn Gly Ile Thr Glu Val Arg Gly His Phe Ile Arg Asp Asn Val
1505 1510 1515 1520
Pro Val Pro Ala Asp Glu Ile Glu Thr Leu Arg Gly Asp Met Val Leu
1525 1530 1535
Leu Thr Ala Ile Gln Ser Thr Leu Ala Thr Arg Leu Leu Val Leu Arg
1540 1545 1550
Asp Leu Phe Thr Asp Thr Ser Pro Ala Pro Asp Ala Gly Ser Ala Ala
1555 1560 1565
Val Leu Tyr Ala Leu Ala Val Leu Ser Ala Leu Leu Ala Ala Leu Cys
1570 1575 1580
Leu Leu Leu Leu Val Ile Phe Ile Ile Arg Thr Lys Lys Leu Asn Arg
1585 1590 1595 1600
Arg Leu Glu Ala Leu Thr Val Lys Lys Tyr Gly Ser Val Asp Ser Gly
1605 1610 1615
Leu Asn Arg Val Gly Ile Ala Ala Pro Gly Thr Asn Lys His Ala Val
1620 1625 1630
Glu Gly Ser Asn Pro Ile Trp Asn Glu Thr Ile Lys Ala Pro Asp Phe
1635 1640 1645
Asp Ser Met Ser Asp Ala Ser Asn Asp Ser Asp Leu Ile Gly Ile Glu
1650 1655 1660
Asp Leu Pro His Phe Gly Glu Asn Asn Tyr Phe Pro Arg Asp Val Asp
1665 1670 1675 1680
Glu Phe Lys Thr Asp Lys Pro Glu Asp Ile Val Ala Thr His Asn Asn
1685 1690 1695
Asn Phe Gly Phe Lys Ser Thr Pro Phe Ser Pro Glu Phe Ala Asn Gln
1700 1705 1710
Phe Gln Lys
1715
<210> SEQ ID NO 18
<211> LENGTH: 1717
<212> TYPE: PRT
<213> ORGANISM: Tobacco hornworm
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<400> SEQUENCE:
Met Ala Val Asp
1
Pro
Arg
Thr
Cys
65
Ile
Asn
Gly
Glu
Met
145
Ala
Ile
Leu
Thr
Thr
225
Asn
Leu
Thr
Arg
Gln
305
Pro
Ile
Pro
val
val
385
Lys
Ala
Leu
Trp
50
Met
Tyr
Tyr
ser
Trp
130
Gln
Gly
Gln
Thr
Glu
210
Phe
Met
His
val
Trp
290
Asn
Ile
Glu
Ile
Ala
370
Ile
Glu
val
Pro
35
ser
Asp
Met
Asn
Tyr
115
His
Gln
val
Asn
Glu
195
Phe
Tyr
Thr
Ile
Thr
275
Leu
Phe
Asn
Ala
Asp
355
Tyr
Ile
Tyr
Leu
20
Arg
Gln
Ala
Asp
Gly
100
Asn
Leu
Tyr
ser
Phe
180
Cys
Met
Ile
Ile
Phe
260
Met
Glu
Thr
Tyr
Leu
340
Arg
Lys
val
Arg
18
val
Ala
Pro
Arg
Tyr
Glu
85
Pro
Leu
Ile
Met
Leu
165
Glu
Thr
Thr
Glu
Gly
245
ser
Met
Ile
val
Arg
325
Pro
Asp
Tyr
Thr
Leu
Arg
Gln
Asp
Pro
His
Glu
ser
Leu
Ile
Phe
150
Ala
Pro
Tyr
Phe
Arg
230
val
val
val
Phe
Arg
310
Leu
Gly
Thr
Asp
Asp
390
Ala
Ile
Glu
Asn
Leu
55
val
Ile
Thr
Met
Thr
135
Asn
Ile
Cys
Gln
Arg
215
Thr
Asn
Thr
Gln
Ala
295
Ala
Ile
Gly
Leu
Glu
375
Ile
Ile
Ala
Arg
Leu
40
Leu
Ile
Glu
Pro
Pro
120
Gln
val
val
Arg
val
200
Ile
Asn
Thr
Ala
val
280
val
Ile
Thr
Lys
Gln
360
Glu
Asn
Met
Ala
Cys
25
Pro
Pro
Thr
Asp
Phe
105
val
Arg
Arg
Asn
val
185
ser
Asp
Ile
ser
Leu
265
Ala
Gln
Asp
Asn
ser
345
Arg
Ala
Asp
Glu
Phe
Gly
val
Ala
Ala
Glu
90
Ile
Ile
Gln
val
Ile
170
Pro
Asp
ser
Pro
Leu
250
Asp
Asn
Gln
Gly
Glu
330
Gly
Glu
Phe
Gln
Glu
Leu
Tyr
Leu
Pro
Asn
75
Ile
Glu
Arg
His
Asp
155
Asp
Glu
Ala
val
Asn
235
Asn
ser
val
Phe
Asp
315
Glu
Ala
val
ser
Arg
395
Thr
Leu
Met
Asn
Glu
60
Leu
Thr
Leu
Arg
Tyr
140
Gly
Asp
Leu
Asp
Arg
220
Gln
Phe
Leu
Asn
Glu
300
Thr
Asp
val
Phe
Thr
380
Pro
Pro
val
Thr
Phe
45
Arg
Gly
Ile
Pro
val
125
Glu
Gln
Asn
Gly
Gly
205
Gly
Trp
val
Pro
ser
285
Glu
Glu
Thr
Phe
Pro
365
ser
Glu
Leu
Phe
Ala
30
Glu
Asp
Thr
Ala
Phe
110
Asp
Leu
ser
Ala
Glu
190
Arg
Asp
Met
Thr
Asn
270
Arg
Lys
Ile
Phe
Leu
350
Leu
Thr
Pro
Thr
Ile
Ile
Gly
Asp
Gln
Ile
95
Leu
Asn
Pro
Leu
Pro
175
Pro
Ile
Glu
Trp
ser
255
Thr
Pro
ser
Asn
Phe
335
val
Thr
Asn
Ile
Leu
Ala
Pro
Gln
Leu
val
Leu
ser
Gly
Gly
val
160
Ile
Gly
ser
Glu
Leu
240
Pro
His
Pro
Tyr
Met
320
ser
ser
Ile
val
His
400
Asn
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Phe
Gln
Ala
Met
465
Gln
Glu
Thr
Asp
545
Phe
Asp
Ala
val
Pro
625
Ile
Arg
Gln
Phe
Arg
705
Leu
Asp
Asn
Arg
Asp
785
Arg
Gln
Asp
Tyr
Phe
450
Gly
ser
val
Gln
Glu
530
Ile
Leu
ser
Thr
Ile
610
Arg
Thr
Phe
Ala
Pro
690
Glu
ser
Tyr
Ala
Glu
770
Ile
Glu
Ile
Lys
Thr
435
Tyr
Thr
Ile
Gly
Pro
515
Gly
Gly
Thr
Phe
Asp
595
Arg
Gly
Gln
Glu
Asn
675
Glu
Ile
Leu
Asp
Pro
755
Met
Asp
Asp
ser
Glu
420
val
Ile
Leu
Thr
val
500
Ile
Glu
Asp
Ile
Asn
580
Thr
Leu
ser
Glu
Ile
660
Pro
Ile
Arg
Thr
Glu
740
val
ser
Gly
Thr
val
820
405
Phe
Arg
Ala
Asn
Ile
485
Ala
Phe
Gly
val
Asp
565
Tyr
Leu
Asn
Pro
Leu
645
Asn
Asp
Asn
His
val
725
ser
Trp
Ala
Pro
Asp
805
Asn
Gly
Leu
Pro
His
470
Arg
Leu
Glu
Phe
val
550
Lys
His
Gly
Asp
Gln
630
Arg
Trp
Glu
Asn
Asn
710
Arg
Met
val
Gly
Leu
790
Lys
Thr
Phe
Glu
Glu
455
ser
val
val
His
Phe
535
Glu
Leu
Arg
Glu
Ile
615
val
Ala
Asp
Phe
Arg
695
val
val
Leu
Glu
Gly
775
Tyr
Asp
ser
His
ser
440
val
Met
val
His
Ala
520
val
His
Thr
Glu
Pro
600
Asn
Glu
Thr
Thr
Arg
680
Gly
Thr
Arg
Thr
Gly
760
Leu
Asn
Leu
Gly
Asp
425
val
Gly
Leu
Ala
Ile
505
val
Ala
Thr
Gly
ser
585
Phe
Asn
Glu
Asp
ser
665
Asn
Leu
Ile
Asp
Ile
745
Thr
val
Gln
Ile
Ala
825
410
Lys
Asp
Tyr
Asp
Thr
490
Asp
Gln
Lys
Leu
Asp
570
Glu
His
Thr
Asn
Pro
650
Phe
Cys
Ala
Asp
Leu
730
Thr
Leu
val
val
Met
810
Ile
Asp
Pro
Gln
Tyr
475
Asp
Leu
Thr
Ala
Leu
555
Ile
Leu
Thr
Pro
val
635
Asp
Ala
val
Ile
Tyr
715
Asn
Ile
Glu
Gly
Arg
795
Ile
Asp
Leu
Pro
Arg
460
Glu
Asn
Ile
val
val
540
Gly
Arg
Phe
Ala
Pro
620
Pro
Thr
Thr
Glu
Gly
700
Glu
Thr
Ile
Gln
ser
780
Tyr
Asp
Ala
Gly
Gly
445
Gln
val
Asn
Asn
Thr
525
Ala
Asn
val
val
Thr
605
Thr
Asp
Thr
Lys
Ile
685
Arg
Glu
val
Asp
Asn
765
val
Thr
Phe
Asp
Gln
430
Ala
Thr
Pro
Asp
Trp
510
Phe
His
Ala
ser
Gln
590
ser
Leu
Gly
Ala
Gln
670
Glu
val
Phe
Tyr
Met
750
Phe
Arg
Ile
Leu
Thr
830
415
Asn
Ala
Phe
Glu
Thr
495
Asn
Asp
Asp
val
Ala
575
val
Gln
Arg
His
Asp
655
Gly
Thr
val
Glu
Gly
735
Asn
Arg
Ala
Phe
Thr
815
Pro
Ala
Glu
Ile
Phe
480
Arg
Asp
Glu
Arg
Asn
560
Asn
Arg
Leu
Leu
val
640
Leu
Arg
Ile
Ala
val
720
Asp
Asp
val
Asp
Pro
800
Gly
Pro
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Arg Phe His Leu Tyr Tyr Thr Val Val Ala Ser Asp Arg Cys Ser Thr
835 840 845
Glu Asp Pro Ala Asp Cys Pro Pro Asp Pro Thr Tyr Trp Glu Thr Glu
850 855 860
Gly Asn Ile Thr Ile His Ile Thr Asp Thr Asn Asn Lys Val Pro Gln
865 870 875 880
Ala Glu Thr Thr Lys Phe Asp Thr Val Val Tyr Ile Tyr Glu Asn Ala
885 890 895
Thr His Leu Asp Glu Val Val Thr Leu Ile Ala Ser Asp Leu Asp Arg
900 905 910
Asp Glu Ile Tyr His Thr Val Ser Tyr Val Ile Ile Asn Tyr Ala Val
915 920 925
Asn Pro Arg Leu Met Asn Phe Phe Ser Val Asn Arg Glu Thr Gly Leu
930 935 940
Val Tyr Val Asp Tyr Glu Thr Gln Gly Ser Gly Glu Val Leu Asp Arg
945 950 955 960
Asp Gly Asp Glu Pro Thr His Arg Ile Phe Phe Asn Leu Ile Asp Asn
965 970 975
Phe Met Gly Glu Gly Glu Gly Asn Arg Asn Gln Asn Asp Thr Glu Val
980 985 990
Leu Val Ile Leu Leu Asp Val Asn Asp Asn Ala Pro Glu Leu Pro Pro
995 1000 1005
Pro Ser Glu Leu Ser Trp Thr Ile Ser Glu Asn Leu Lys Gln Gly Val
1010 1015 1020
Arg Leu Glu Pro His Ile Phe Ala Pro Asp Arg Asp Glu Pro Asp Thr
1025 1030 1035 1040
Asp Asn Ser Arg Val Gly Tyr Glu Ile Leu Asn Leu Ser Thr Glu Arg
1045 1050 1055
Asp Ile Glu Val Pro Glu Leu Phe Val Met Ile Gln Ile Ala Asn Val
1060 1065 1070
Thr Gly Glu Leu Glu Thr Ala Met Asp Leu Lys Gly Tyr Trp Gly Thr
1075 1080 1085
Tyr Ala Ile His Ile Arg Ala Phe Asp His Gly Ile Pro Gln Met Ser
1090 1095 1100
Met Asn Glu Thr Tyr Glu Leu Ile Ile His Pro Phe Asn Tyr Tyr Ala
1105 1110 1115 1120
Pro Glu Phe Val Phe Pro Thr Asn Asp Ala Val Ile Arg Leu Ala Arg
1125 1130 1135
Glu Arg Ala Val Ile Asn Gly Val Leu Ala Thr Val Asn Gly Glu Phe
1140 1145 1150
Leu Glu Arg Ile Ser Ala Thr Asp Pro Asp Gly Leu His Ala Gly Val
1155 1160 1165
Val Thr Phe Gln Val Val Gly Asp Glu Glu Ser Gln Arg Tyr Phe Gln
1170 1175 1180
Val Val Asn Asp Gly Glu Asn Leu Gly Ser Leu Arg Leu Leu Gln Ala
1185 1190 1195 1200
Val Pro Glu Glu Ile Arg Glu Phe Arg Ile Thr Ile Arg Ala Thr Asp
1205 1210 1215
Gln Gly Thr Asp Pro Gly Pro Leu Ser Thr Asp Met Thr Phe Arg Val
1220 1225 1230
Val Phe Val Pro Thr Gln Gly Glu Pro Arg Phe Ala Ser Ser Glu His
1235 1240 1245
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Ala Val Ala Phe Ile Glu Lys Ser Ala Gly Met Glu Glu Ser His Gln
1250 1255 1260
Leu Pro Leu Ala Gln Asp Ile Lys Asn His Leu Cys Glu Asp Asp Cys
1265 1270 1275 1280
His Ser Ile Tyr Tyr Arg Ile Ile Asp Gly Asn Ser Glu Gly His Phe
1285 1290 1295
Gly Leu Asp Pro Val Arg Asn Arg Leu Phe Leu Lys Lys Glu Leu Ile
1300 1305 1310
Arg Glu Gln Ser Ala Ser His Thr Leu Gln Val Ala Ala Ser Asn Ser
1315 1320 1325
Pro Asp Gly Gly Ile Pro Leu Pro Ala Ser Ile Leu Thr Val Thr Val
1330 1335 1340
Thr Val Arg Glu Ala Asp Pro Arg Pro Val Phe Val Arg Glu Leu Tyr
1345 1350 1355 1360
Thr Ala Gly Ile Ser Thr Ala Asp Ser Ile Gly Arg Glu Leu Leu Arg
1365 1370 1375
Leu His Ala Thr Gln Ser Glu Gly Ser Ala Ile Thr Tyr Ala Ile Asp
1380 1385 1390
Tyr Asp Thr Met Val Val Asp Pro Ser Leu Glu Ala Val Arg Gln Ser
1395 1400 1405
Ala Phe Val Leu Asn Ala Gln Thr Gly Val Leu Thr Leu Asn Ile Gln
1410 1415 1420
Pro Thr Ala Thr Met His Gly Leu Phe Lys Phe Glu Val Thr Ala Thr
1425 1430 1435 1440
Asp Thr Ala Gly Ala Gln Asp Arg Thr Asp Val Thr Val Tyr Val Val
1445 1450 1455
Ser Ser Gln Asn Arg Val Tyr Phe Val Phe Val Asn Thr Leu Gln Gln
1460 1465 1470
Val Glu Asp Asn Arg Asp Phe Ile Ala Asp Thr Phe Ser Ala Gly Phe
1475 1480 1485
Asn Met Thr Cys Asn Ile Asp Gln Val Val Pro Ala Asn Asp Pro Val
1490 1495 1500
Thr Gly Val Ala Leu Glu His Ser Thr Gln Met Arg Gly His Phe Ile
1505 1510 1515 1520
Arg Asp Asn Val Pro Val Leu Ala Asp Glu Ile Glu Gln Ile Arg Ser
1525 1530 1535
Asp Leu Val Leu Leu Ser Ser Ile Gln Thr Thr Leu Ala Ala Arg Ser
1540 1545 1550
Leu Val Leu Asp Leu Leu Thr Asn Ser Ser Pro Asp Ser Ala Pro Asp
1555 1560 1565
Ser Ser Leu Thr Val Tyr Val Leu Ala Ser Leu Ser Ala Val Leu Gly
1570 1575 1580
Phe Met Cys Leu Val Leu Leu Leu Thr Phe Ile Ile Arg Thr Arg Ala
1585 1590 1595 1600
Leu Asn Arg Arg Leu Glu Ala Leu Ser Met Thr Lys Tyr Gly Ser Leu
1605 1610 1615
Asp Ser Gly Leu Asn Arg Ala Gly Ile Ala Ala Pro Gly Thr Asn Lys
1620 1625 1630
His Thr Val Glu Gly Ser Asn Pro Ile Phe Asn Glu Ala Ile Lys Thr
1635 1640 1645
Pro Asp Leu Asp Ala Ile Ser Glu Gly Ser Asn Asp Ser Asp Leu Ile
1650 1655 1660
Gly Ile Glu Asp Leu Pro His Phe Gly Asn Val Phe Met Asp Pro Glu
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1665 1670 1675 1680
Val Asn Glu Lys Ala Asn Gly Tyr Pro Glu Val Ala Asn His Asn Asn
1685 1690 1695
Asn Phe Ala Phe Asn Pro Thr Pro Phe Ser Pro Glu Phe Val Asn Gly
1700 1705 1710
Gln Phe Arg Lys Ile1715
Whatis claimedis: 4. The isolated protein of claim 1, wherein the protein
1. An isolated protein which binds cry1 A(c), wherein said 15 comprises an amino acid sequenceat least 95% homologous
protein comprises to positions 1-1729 of SEQ.ID. No.: 2.
a) the amino acid sequence at positions 1269-1367 of 5. The isolated protein of claim 4, which comprises theSEQ. ID. No.: 2; or i id f positions 1-1729 of SEQ. ID. No.:b) the amino acid sequenceat positions 24-1729 of SEQ. BENE SETIENCE OF Postsens ° QD. No.
ID. No.: 2.; or 20 . . . . .c) an amino acid sequenceat least 95% homologous to 6. A method to identify a candidate pesticide against P
positions 1-1729 of SEQ. ID. No.: 2 gossypiella, which method comprises contacting a test com-
poundwith the protein of claim 1 and assessing the ability2. The isolated protein of claim 1, wherein the protein : ° : .P P of said test compoundto bind to said proteincomprises the amino acid sequence at positions 1269-1367
of SEQ. ID. No.: 2. 25 wherein a test protein that binds to said protein is iden-
3. The isolated protein of claim 1, wherein the protein tified as a candidate pesticide against P. gossypiella.
comprises the amino acid sequenceat positions 24-1729 of
SEQ.ID. No.: 2. # oe oF
